Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1050.Time spend outdoors in summer,44997,0.0343990996883303,0.0163019724443625,0.00244723369737975,0.0663509656792809,0.0348536249035316
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1060.Time spent outdoors in winter,39254,-0.0279821833816827,0.018245557263649,-0.0637434756184347,0.0077791088550693,0.125125401164401
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X1070.Time spent watching television (TV),47304,0.0591757768575489,0.0164286538914058,0.0269756152303936,0.0913759384847042,0.000316119152308601
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X1080.Time spent using computer,39233,-0.0389731315976122,0.0166748607283797,-0.0716558586252364,-0.00629040456998796,0.0194317744230416
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X1090.Time spent driving,34011,-0.0104349279393395,0.0181997036114454,-0.0461063470177725,0.0252364911390936,0.566406773571649
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1160.Sleep duration,49861,0.00296661817207478,0.0148469057926963,-0.02613331718161,0.0320665535257595,0.841626943816757
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,16690,-0.0172282078823461,0.0136163597187087,-0.0439162729310152,0.00945985716632296,0.205796540763481
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,16690,-0.00443536018676188,0.0133035085378256,-0.0305102369209,0.0216395165473763,0.738838231824768
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,16690,-0.0194747693330114,0.0152041968309886,-0.0492749951217489,0.0103254564557262,0.200253222874053
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,16690,-0.0250782198702424,0.0155220571185485,-0.0555014518225974,0.00534501208211269,0.106188808596018
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,16690,0.0106710436505745,0.0158147166050304,-0.0203258008952851,0.0416678881964342,0.49984140996127
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,16690,-0.0067643486095094,0.0334981158351864,-0.0724206556464747,0.0588919584274559,0.839972182845904
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,16690,0.00546502399340757,0.0349527211195474,-0.0630423094009054,0.0739723573877205,0.875755294900012
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,16690,0.00618654013370336,0.0238356352561509,-0.0405313049683524,0.0529043852357592,0.795214080450614
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,16690,0.0180848959502329,0.0175244053417605,-0.0162629385196177,0.0524327304200835,0.302094845744028
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,16690,0.0131712042132823,0.0120016754307657,-0.0103520796310186,0.0366944880575831,0.27246182818764
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,16690,0.0175279147714452,0.0173946380247599,-0.0165655757570842,0.0516214052999746,0.313631400953004
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,16690,0.00241970309188402,0.00972218697200604,-0.0166357833732478,0.0214751895570159,0.803453075095872
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,16690,-0.00600108422748839,0.0125958066292778,-0.0306888652208728,0.0186866967658961,0.633770684957249
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,16690,0.0390288605869497,0.0186649289042765,0.00244559993456774,0.0756121212393318,0.0365407869938404
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,16690,-0.00118283763504838,0.0177101451744605,-0.0358947221769909,0.0335290469068941,0.946750717295382
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,16690,-0.0197711999020693,0.0235488165414692,-0.0659268803233489,0.0263844805192104,0.401153939892416
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,16690,-0.00748079924020913,0.0222093965615209,-0.05101121650079,0.0360496180203717,0.736249016954434
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,16690,0.0227745680899879,0.0136261824148968,-0.00393274944320989,0.0494818856231857,0.0946648369644986
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,16690,0.0170067073936941,0.0129719383333432,-0.00841829173965859,0.0424317065270468,0.189862892152452
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,16690,-0.0196559938952761,0.0161237804781963,-0.0512586036325408,0.0119466158419886,0.222835414069961
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120040.Fatigue severity over the past week,16703,0.0352162527162213,0.0277432080549272,-0.0191604350714361,0.0895929405038787,0.20432867515076
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120041.Waking unrefreshed severity over the past week,16703,0.0258731916941476,0.0275198751988067,-0.0280657636955136,0.0798121470838087,0.347147132647624
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120042.Cognitive symptoms severity over the past week,16702,0.0142765690449904,0.0297303533893675,-0.0439949235981699,0.0725480616881508,0.631090205963937
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120098.Mobility problems today,16711,0.0188587217650111,0.0319562382921071,-0.0437755052875188,0.0814929488175411,0.55510336961462
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120099.Self-care problems today,16711,0.0133980079081795,0.0488397279499217,-0.0823278588736671,0.109123874690026,0.783837488849876
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120100.Problems doing usual activities,16711,0.0343596890162233,0.0304803387426117,-0.0253817749192956,0.0941011529517422,0.259642914220253
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120101.Pain or discomfort today,16711,0.00182028664601549,0.0276860593089748,-0.0524443895995751,0.0560849628916061,0.947579714942611
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120102.Anxiety or depression today,16711,-0.0172063667639892,0.0335287650953861,-0.0829227463509459,0.0485100128229675,0.607830639164452
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120103.Scale to indicate how health is today,16656,-0.00465456642583105,0.00422008874871857,-0.0129259403733194,0.00361680752165735,0.270062817182569
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,16671,6.75224919436109e-05,0.0336543335378145,-0.0658949712421728,0.06603001622606,0.998399186573285
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",16649,-0.0488137027121292,0.0348605340576784,-0.117140349465179,0.0195129440409204,0.161455060594414
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",16681,0.00268765434896265,0.0276058926856612,-0.0514198953149332,0.0567952040128585,0.922443272515276
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,16682,-0.0168684399474323,0.0282813995112287,-0.0722999829894406,0.0385631030945759,0.550882766526943
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,16688,0.00596998971442524,0.0361630324509422,-0.0649095538894216,0.076849533318272,0.868878743387262
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120109.Feeling bad about self over the last two weeks,16644,-0.0135926222782873,0.0364982633776244,-0.0851292184984312,0.0579439739418565,0.70958615517689
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120110.Trouble concentrating over the last two weeks,16688,-0.00183814888875086,0.0364822560919837,-0.0733433708290388,0.0696670730515371,0.959816402404781
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,16671,-0.0110382559877755,0.052554168814678,-0.114044426864544,0.0919679148889934,0.833642314403741
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,16601,0.0502182750220139,0.0706282136042848,-0.0882130236423842,0.188649573686412,0.477080063943304
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",11616,0.0312298675566127,0.0368348956039448,-0.0409665278271191,0.103426262940344,0.396548059075457
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,45096,0.0844932511450991,0.036570322013815,0.0128154199980217,0.156171082292176,0.0208687272874801
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,42084,0.0391072883250667,0.0229816916415658,-0.00593682729240222,0.0841514039425356,0.0888243660227314
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1289.Cooked vegetable intake,48423,-0.0223099718216218,0.0155091030848417,-0.0527078138679115,0.00808787022466781,0.150296380103715
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,47109,-0.0736234998504635,0.0163002593794133,-0.105572008234114,-0.0416749914668134,6.29609133103105e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1309.Fresh fruit intake,48313,-0.0840328116931993,0.016291666512589,-0.115964478057874,-0.0521011453285249,2.50552967859605e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1319.Dried fruit intake,45635,-0.0668806664131102,0.0169531443382823,-0.100108829316144,-0.0336525035100769,7.99092187207577e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X134.Number of self-reported cancers,50291,0.0758817805674376,0.0282578195611763,0.020496454227532,0.131267106907343,0.00724803884475384
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X135.Number of self-reported non-cancer illnesses,50292,0.024799223555871,0.0154811967842768,-0.00554392214131164,0.0551423692530536,0.109185515057821
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X136.Number of operations, self-reported",50292,0.0369142332542565,0.0151642209079794,0.00719236027461696,0.0666361062338961,0.0149241598964742
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X137.Number of treatments or medications taken,50292,0.0289131614152277,0.0151200944682797,-0.000722223742600413,0.0585485465730559,0.0558518408674701
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1438.Bread intake,48817,0.00980828252749616,0.00267726079861495,0.00456085136221085,0.0150557136927815,0.000249005328788524
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1458.Cereal intake,47753,-0.0210413911676106,0.0154243947928732,-0.0512732049616421,0.0091904226264209,0.172522650646532
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1488.Tea intake,48531,0.00713323406690682,0.00255984525969831,0.00211593735789814,0.0121505307759155,0.00532868409743829
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1498.Coffee intake,46337,0.0202876593830344,0.0155054273114011,-0.0101029781473118,0.0506782969133806,0.190736331242114
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1528.Water intake,46484,-0.0884080783439819,0.0156245108024445,-0.119032119516773,-0.0577840371711906,1.53782264471244e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1568.Average weekly red wine intake,34237,-0.116151324876779,0.0182369667220807,-0.151895779652057,-0.0804068701015006,1.92670793458515e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,34231,-0.111618465533199,0.0187645203195561,-0.148396925359529,-0.0748400057068694,2.73438680458952e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1588.Average weekly beer plus cider intake,34322,0.0439768451164097,0.020567438049936,0.00366466653853507,0.0842890236942844,0.0325093366359182
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1598.Average weekly spirits intake,34177,-0.00916441488959446,0.019957925577263,-0.04828194902103,0.0299531192418411,0.646102989697751
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1608.Average weekly fortified wine intake,34297,-0.00218559757196401,0.033270399464213,-0.0673955805218215,0.0630243853778935,0.947623460909419
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1737.Childhood sunburn occasions,37734,-0.0531972207746315,0.0182874677223432,-0.0890406575104242,-0.0173537840388389,0.00362863379117256
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X1807.Father's age at death,37019,-0.0105018259118777,0.00298445953933886,-0.0163513666089819,-0.00465228521477358,0.000433963268348733
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X1845.Mother's age,19119,-0.0205063492275,0.00660150545665277,-0.0334452999225394,-0.00756739853246057,0.00189712847915189
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X1873.Number of full brothers,49381,0.0147330010988892,0.0148896531120001,-0.014450719000631,0.0439167211984094,0.32243362256346
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X1883.Number of full sisters,49388,0.00429127153269267,0.0148856204594482,-0.0248845445678258,0.0334670876332112,0.773131318422645
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X20015.Sitting height,49898,0.00282888698119812,0.00337737080566463,-0.00379075979790456,0.0094485337603008,0.402259207078527
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20016.Fluid intelligence score,16121,-0.0240277900020649,0.0250171954057562,-0.073061492997347,0.0250059129932172,0.336842715742655
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20018.Prospective memory result,16795,0.0637991143145231,0.0324783458716047,0.000141556406177898,0.127456672222868,0.0495050126665108
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),15910,-0.0086534541915906,0.00458578222843726,-0.0176415873593276,0.000334678976146439,0.0591760926823222
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),15894,-0.000543946776438597,0.00458189028246108,-0.00952445173006232,0.00843655817718512,0.905501327379094
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20023.Mean time to correctly identify matches,49683,0.00481362067314981,0.00271298058951816,-0.000503821282305777,0.0101310626286054,0.0760209317274247
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#1.Illnesses of father_Heart disease,43740,-0.00389767820871524,0.00573213742597209,-0.0151326675636205,0.00733731114619007,0.496527418477369
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,42867,-0.0365424595902804,0.0126423454634067,-0.0613214566985576,-0.0117634624820032,0.00384845833347535
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,42799,0.0195089237057245,0.0169336758853369,-0.0136810810295359,0.0526989284409849,0.249295259438335
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#12.Illnesses of father_Severe depression,42837,0.00515185259259532,0.0143248359905005,-0.0229248259487856,0.0332285311339762,0.719114559585033
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,42861,-0.0175203589661197,0.0102086133190946,-0.0375292410715451,0.00248852313930571,0.0861266355717471
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#2.Illnesses of father_Stroke,43197,-0.00832667558529436,0.00737561409815365,-0.0227828792176755,0.00612952804708681,0.258926568051203
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,43078,0.00117177680318966,0.00933305714053183,-0.0171210151922527,0.0194645687986321,0.900087756296529
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,42883,0.00856024901406149,0.0116664076385855,-0.0143059099575662,0.0314264079856891,0.46310396081873
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,43159,0.0167062870515175,0.00854167586959039,-3.53976528797151e-05,0.0334479717559146,0.0504885768495545
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,43301,-0.019381255198377,0.00643226200740186,-0.0319884887328846,-0.00677402166386933,0.00258715798810695
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#9.Illnesses of father_Diabetes,43035,-0.0106197698775066,0.00890438483009151,-0.0280723641444859,0.00683282438947278,0.233015019431753
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,45864,0.0163657517860213,0.00661295360611503,0.00340436271803583,0.0293271408540068,0.013334588982932
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,45577,-0.00679086057470726,0.00946990544186185,-0.0253518752407565,0.011770154091342,0.473316633204415
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,45435,0.00414826581423467,0.0204597107864872,-0.0359527673272803,0.0442492989557496,0.839329077168612
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,45504,0.00166571292691321,0.0105972001319353,-0.01910479933168,0.0224362251855065,0.875100340357619
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#2.Illnesses of mother_Stroke,45741,0.0125938490778083,0.00751064764178757,-0.00212702030009532,0.0273147184557119,0.0935885603685376
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,45531,0.0171519809309145,0.0132700787694546,-0.00885737345721646,0.0431613353190455,0.196180067829976
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,45491,0.00507454452490712,0.0119033887933811,-0.0182560975101199,0.0284051865599342,0.669883325868152
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,45532,-0.024991973995024,0.00967219952963796,-0.0439494850731144,-0.00603446291693362,0.00977216278897877
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,45583,0.0454024965186116,0.0111461251162674,0.0235560912907275,0.0672489017464957,4.64123595266892e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,45935,0.00137213668324432,0.00570982935999129,-0.00981912886233862,0.0125634022288273,0.810089985566186
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,45646,0.0101199034064598,0.00880839030441006,-0.00714454159018393,0.0273843484031035,0.250605871548252
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,39332,0.0179965263308488,0.00922257427292243,-7.97192440792072e-05,0.0360727719057767,0.0510217941354626
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,39048,-0.00325776206021134,0.0367956748775986,-0.0753772848203047,0.068861760699882,0.929450690932706
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,39036,-0.0549519110029857,0.0371735172795291,-0.127812004870863,0.0179081828648915,0.139347801531363
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,39156,0.00569848152178261,0.0108607734318031,-0.0155886344045514,0.0269855974481166,0.599805374704305
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,39070,0.0357273112227117,0.0215261073802089,-0.00646385924249783,0.0779184816879212,0.0969788197581791
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,39116,0.00251809886108308,0.0155285390777507,-0.0279178377313083,0.0329540354534744,0.871181154299787
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,39068,0.0329181958510767,0.0184300132932631,-0.00320463020371891,0.0690410219058724,0.0740877573291838
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,39071,-0.00943889602919203,0.0180357422095603,-0.0447889507599303,0.0259111587015462,0.600737911464029
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,39095,-0.0068577385367315,0.0135412531311935,-0.0333985946738707,0.0196831176004077,0.612555513588109
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,39115,0.00293755466164903,0.0166884837049038,-0.0297718733999624,0.0356469827232605,0.860276893265465
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,39469,-0.0172950513569761,0.00687920807159888,-0.0307782991773099,-0.00381180353664227,0.011937436653766
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,39253,-0.0144108561160042,0.00977371026845189,-0.0335673282421699,0.00474561601016154,0.140368245188386
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20127.Neuroticism score,39968,0.0200291330238046,0.0155968285145267,-0.0105406508646677,0.0505989169122769,0.199086479554439
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,16121,-0.00800021373118022,0.0253996447448874,-0.0577835174311595,0.0417830899687991,0.752785895441009
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X20161.Pack years of smoking,15312,0.0909254588802585,0.0053466276328135,0.080446068719944,0.101404849040573,2.87948391310432e-64
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,15312,0.0932506103412312,0.00527062351422068,0.0829201882533586,0.103581032429104,2.3478700811649e-69
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20191.Fluid intelligence score,12437,0.0211862535096474,0.0294571870526468,-0.0365498331135403,0.0789223401328351,0.472017760546119
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,12438,0.0211622319194233,0.0301267033579134,-0.0378861066620869,0.0802105705009336,0.482417350812391
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20240.Maximum digits remembered correctly,11178,0.0174903860273755,0.0315214527577049,-0.0442916613777262,0.0792724334324772,0.578993024745886
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X20255.Spirometry QC measure,37418,-0.0196254316613154,0.0199868695063103,-0.0587996958936837,0.0195488325710528,0.326147467417753
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X20261.avMSE,11018,0.00126491631414936,0.00540818795762121,-0.00933513208278821,0.0118649647110869,0.81507541208611
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X20262.Myopia diagnosis,11018,0.000681144222122934,0.0383146639578622,-0.074415597135287,0.0757778855795329,0.985816566646103
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X20280.Glucose-lactate,28725,-0.00407693754411902,0.00340512330092897,-0.0107509792139398,0.00259710412570175,0.231201427131909
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X20281.Spectrometer-corrected alanine,28788,0.00501810818759322,0.00342098056131633,-0.00168701371258678,0.0117232300877732,0.142424385329297
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,15715,-0.0056946051520556,0.0181877464041795,-0.0413425881042475,0.0299533778001363,0.754207939197486
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,15712,-0.0427695124509518,0.0355836616285746,-0.112513489242958,0.0269744643410544,0.229403967986733
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),15710,0.0118479751197186,0.0438547599688833,-0.0741073544192927,0.0978033046587298,0.78703767845741
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),15710,-0.00870713840850717,0.0172404743858121,-0.0424984682046989,0.0250841913876845,0.613537456670714
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),15710,-0.0644568934999083,0.0299877592701372,-0.123232901669377,-0.00568088533043944,0.0316147649425239
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,15721,0.0108024871783366,0.0382011549363076,-0.0640717764968263,0.0856767508534995,0.777349923513902
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,15721,-0.0376100479411247,0.0249780249631145,-0.0865669768688291,0.0113468809865797,0.13215777602868
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,15721,0.0153437769402614,0.0280076760935342,-0.0395512682030656,0.0702388220835884,0.583808288287541
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,15721,0.0883171555334027,0.0432002870690022,0.00364459287815842,0.172989718188647,0.0409341384056642
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,15721,0.0441021951930525,0.0499719830936078,-0.0538428916704189,0.142047282056524,0.377499216752895
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,15721,0.0141823521678525,0.0291362795999196,-0.0429247558479899,0.071289460183695,0.626435778369564
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,15721,0.0689468755912954,0.0492311110074339,-0.027546101983275,0.165439853165866,0.161391270856244
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,15721,0.0267312195398894,0.0369129891012985,-0.0456182390986556,0.0990806781784344,0.468973153722723
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),15722,0.0706340623223481,0.0503109867496357,-0.027975471706938,0.169243596351634,0.160353790299123
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),15722,0.000240039387266564,0.0231202594320819,-0.0450756690996139,0.0455557478741471,0.991716475645849
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),15722,-0.013204530128832,0.0346842999996101,-0.0811857581280677,0.0547766978704037,0.703426371549583
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,15724,-0.0643229743478516,0.0582166414875019,-0.178427591663355,0.0497816429676522,0.269224256657707
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20600.Liking for adding salt to foods,18192,0.0447269709430757,0.0244804980887314,-0.00325480531083783,0.0927087471969893,0.0677094040954178
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20601.Liking for aniseed,18192,0.0200937614350205,0.0242600644467422,-0.0274559648805942,0.0676434877506352,0.407531338853725
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20602.Liking for apple juice,18192,0.0112009599280897,0.0243095122371283,-0.0364456840566818,0.0588476039128612,0.644973098176198
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20603.Liking for apples,18192,-0.0801882239761234,0.0247507067917094,-0.128699609287874,-0.031676838664373,0.00119813650042806
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20604.Liking for asparagus,18192,-0.105341483602736,0.0246681604417852,-0.153691078068635,-0.0569918891368373,1.96164392483715e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20605.Liking for aubergine,18192,-0.120338352493051,0.0244183388868944,-0.168198296711364,-0.0724784082747383,8.3723243150489e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20606.Liking for avocados,18192,-0.0743726118163791,0.0246682550304679,-0.122722391676096,-0.0260228319566619,0.00257408904446265
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20607.Liking for bacon,18192,0.0068387823121263,0.0246862318770756,-0.0415462321669418,0.0552237967911944,0.781761606417442
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20608.Liking for baked or steamed fish,18192,-0.0130299023214939,0.0248368356964251,-0.061710100286487,0.0356502956434993,0.599853736859174
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20609.Liking for bananas,18192,0.0124593207862533,0.0251487048212739,-0.0368321406634436,0.0617507822359502,0.620305477849149
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,18192,-0.0510492297883445,0.0245359922302438,-0.0991397745596224,-0.00295868501706661,0.0374858379512863
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20611.Liking for beef steak,18192,-0.0545441558640416,0.0245794967749542,-0.102719969542952,-0.00636834218513129,0.026492795496748
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20612.Liking for beetroot,18192,0.0268560403501548,0.0246368566025689,-0.0214321985908802,0.0751442792911899,0.275694226851684
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20613.Liking for bell pepper,18192,-0.074212989039004,0.0245282506384419,-0.12228836029035,-0.0261376177876578,0.00248476840946309
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20614.Liking for bicycling,18192,-0.060820735477598,0.0242945235380015,-0.108438001612081,-0.0132034693431149,0.0123067336030967
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20615.Liking for biscuits,18192,-0.0181580233551317,0.0244205397878499,-0.0660222813393175,0.0297062346290542,0.4571551302894
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20616.Liking for bitter foods,18192,-0.0114633471546045,0.0243747309225502,-0.0592378197628029,0.0363111254535939,0.638148944946758
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20617.Liking for bitter or ale,18192,0.0151760781350535,0.0248110697058289,-0.0334536184883712,0.0638057747584781,0.540766671385486
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20618.Liking for black olives,18192,-0.0567751696631774,0.0244764239658916,-0.104748960636325,-0.00880137869002984,0.0203743133776474
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20619.Liking for black pepper,18192,-0.0411815527791413,0.0246276571866768,-0.0894517608650277,0.00708865530674518,0.0945086371479343
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20620.Liking for blue cheese,18192,-0.0533100515305288,0.0244805627764258,-0.101291954572323,-0.00532814848873434,0.0294450640878144
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20621.Liking for bolognese sauce,18192,-0.0195604736349539,0.0245513159470768,-0.0676810528912244,0.0285601056213167,0.425625278304266
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20622.Liking for broad beans,18192,-0.040800773338509,0.0243888762291782,-0.0886029707476984,0.00700142407068029,0.0943591760211763
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20623.Liking for broccoli,18192,-0.0486471805305472,0.0252515160478259,-0.0981401519842859,0.000845790923191453,0.054056885119067
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20624.Liking for brown rice,18192,-0.0689329243079425,0.0244856191369981,-0.116924737816459,-0.0209411107994262,0.00487930897339334
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20625.Liking for brussel sprouts,18192,-0.00814098533227243,0.0247536558560123,-0.0566581508100565,0.0403761801455117,0.742250090959233
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20626.Liking for burgers (meat),18192,-0.0117987589358029,0.0243490576292209,-0.0595229118890758,0.03592539401747,0.627989102386082
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20627.Liking for burn of spicy foods,18192,-0.0291047346953822,0.0242786595021248,-0.0766909073195468,0.0184814379287824,0.230629724764729
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20628.Liking for butter on bread,18192,0.0345630204689302,0.024766136782636,-0.0139786076250363,0.0831046485628967,0.162859337235919
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20629.Liking for butternut squash,18192,-0.0787379843351091,0.0243975224942035,-0.126557128423748,-0.0309188402464703,0.00125188398014769
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20630.Liking for cabbage,18192,0.0061262047712204,0.0246323839980577,-0.0421532678649727,0.0544056774074135,0.803591549827894
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20631.Liking for cake,18192,0.00244652751719361,0.024359689906082,-0.045298464698727,0.0501915197331142,0.920001328785216
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20632.Liking for cake icing,18192,0.0493811966786875,0.0242756750014505,0.00180087367584451,0.0969615196815305,0.0419475125890476
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20633.Liking for capers,18192,-0.0570836892284789,0.0242922014104195,-0.104696403992901,-0.00947097446405672,0.0187902475890752
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20634.Liking for cauliflower,18192,0.00952321672817745,0.0249498866854255,-0.0393785611752565,0.0584249946316114,0.702692972906354
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20635.Liking for cereal or granola bar,18192,-0.00287254901847072,0.0240907341945773,-0.0500903880398423,0.0443452900029008,0.905087526289421
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20636.Liking for cheesecake,18192,0.0371951445650524,0.0243871327080652,-0.0106036355427555,0.0849939246728602,0.127227753366658
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20637.Liking for cherries,18192,-0.0681677621570243,0.0256224196527311,-0.118387704676377,-0.0179478196376714,0.00780994588901596
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20638.Liking for chicken,18192,-0.0310331160891601,0.0255956180376265,-0.0812005274429081,0.0191342952645878,0.22536028580591
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20639.Liking for chilli pepper,18192,-0.0267774431702303,0.0243264003787997,-0.0744571879126778,0.0209023015722171,0.271017234588576
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20640.Liking for chips or french fries,18192,0.0302164576840848,0.0244750537936846,-0.017754647751537,0.0781875631197067,0.217002126362353
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20641.Liking for cigarette smoking,18192,0.146396618782118,0.0380915852774625,0.0717371116382916,0.221056125925944,0.000121814159851539
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20642.Liking for cod,18192,-0.00741198633010606,0.0251506749158343,-0.0567073091651413,0.0418833365049292,0.768223926189637
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20643.Liking for coffee with sugar,18192,0.0988236115589364,0.0264210532928802,0.0470383471048913,0.150608876012982,0.000184339245118897
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20644.Liking for coffee without sugar,18192,-0.0749507468749375,0.0247911423382719,-0.12354138585795,-0.0263601078919246,0.00250393401591175
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20645.Liking for coriander,18192,-0.0553126667265529,0.0243697414529044,-0.103077359974246,-0.00754797347886033,0.0232358006048444
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20646.Liking for corn flakes,18192,0.0647060274284993,0.0243036430284052,0.0170708870928251,0.112341167764174,0.00776538607451252
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20647.Liking for cream,18192,0.0523962134916238,0.0243013938668902,0.00476548151251904,0.100026945470729,0.0310890112131232
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20648.Liking for croissant,18192,-0.00756855620738985,0.0242737077940989,-0.0551450234838236,0.0400079110690439,0.755195659738336
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20649.Liking for cucumber,18192,-0.0549992288428123,0.0246949523481771,-0.103401335445239,-0.00659712224038505,0.0259498176097899
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20650.Liking for curry,18192,-0.0244324702454802,0.0247294723488465,-0.0729022360492195,0.024037295558259,0.323170724999523
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20651.Liking for dairy products,18192,-0.00521748842372891,0.0246487574991291,-0.0535290531220218,0.043094076274564,0.832364148747818
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20652.Liking for dark chocolate,18192,0.0326791302485387,0.0246556640321521,-0.0156459712544795,0.0810042317515568,0.185048283500004
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20653.Liking for diet fizzy drinks,18192,-0.018029635210345,0.0249898653883951,-0.0670097713715995,0.0309505009509094,0.470624826633167
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20654.Liking for dried fruit,18192,-0.0341621975807077,0.0246018319638573,-0.0823817882298679,0.0140573930684525,0.164970280661259
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20655.Liking for eggs,18192,0.0176246132473866,0.0253217657497889,-0.0320060476221996,0.0672552741169729,0.486421303945049
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20656.Liking for exercising alone,18192,-0.0471307879006791,0.0243148268092277,-0.0947878484467654,0.000526272645407139,0.0525952867208153
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20657.Liking for exercising with others,18192,-0.00697168272702526,0.0242209361830137,-0.054444717645732,0.0405013521916815,0.773474761074142
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20658.Liking for extra virgin olive oil,18192,-0.035964477359049,0.0247693144978601,-0.0845123337748547,0.0125833790567568,0.146525240711944
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20659.Liking for fatty foods,18192,0.0101107128859527,0.0244460026214062,-0.0378034522520034,0.0580248780239088,0.679176563016991
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20660.Liking for fresh tomatoes,18192,-0.0229670515141007,0.0261848825234906,-0.0742894212601423,0.0283553182319409,0.38043788499135
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20661.Liking for fried chicken,18192,0.0107701951373649,0.0241073807078175,-0.0364802710499573,0.0580206613246871,0.655054227218059
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20662.Liking for fried or battered fish,18192,0.0473709303813326,0.0244206760462025,-0.000493594669224322,0.0952354554318896,0.0524209352773397
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20663.Liking for fruit,18192,-0.0666774651010717,0.0269847079959238,-0.119567492773082,-0.013787437429061,0.0134851278311964
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20664.Liking for garlic,18192,-0.0526341187523442,0.0247578146760553,-0.101159435517413,-0.00410880198727574,0.0335200530241335
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20665.Liking for gherkins,18192,-0.022469252915296,0.0243471594685055,-0.0701896854735669,0.0252511796429748,0.356087428226195
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20666.Liking for globe artichoke,18192,-0.0954936160679016,0.0242822714963884,-0.143086868200823,-0.0479003639349802,8.43272887072852e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20667.Liking for goat's cheese,18192,-0.0558115672117137,0.0244106572600687,-0.103656455441448,-0.00796667898197912,0.0222446187807515
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20668.Liking for going to a cafe,18192,0.00443930775247823,0.0244462052092549,-0.0434752544576614,0.0523538699626179,0.85590262708315
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20669.Liking for going to the gym,18192,-0.0570334238386076,0.0241625145572122,-0.104391952370744,-0.00967489530647167,0.0182652872401178
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20670.Liking for going to the pub,18192,-0.00700306314521759,0.0244417879193355,-0.0549089674671152,0.04090284117668,0.774483079538492
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20671.Liking for grapefruit,18192,-0.0720751193008039,0.0242965347276045,-0.119696327366909,-0.0244539112346992,0.00301624560363394
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20672.Liking for green olives,18192,-0.0444654964442573,0.0245535702148145,-0.0925904940652937,0.00365950117677901,0.0701637860514022
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20673.Liking for haddock,18192,-0.0178210453884607,0.0250030555387184,-0.0668270342443487,0.0311849434674272,0.476006713952343
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20674.Liking for ham,18192,-0.0176817652464053,0.0245007915452576,-0.0657033166751102,0.0303397861822996,0.470499674623065
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20675.Liking for hard cheese,18192,0.0446091064478702,0.0249982842270749,-0.00438753063719669,0.0936057435329371,0.0743612900791374
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20676.Liking for herring,18192,0.00430158837230941,0.024267945767508,-0.0432635853320063,0.0518667620766252,0.859310924652615
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20677.Liking for honey,18192,-0.0215109277224033,0.0245211414369246,-0.0695723649387756,0.0265505094939689,0.380367857329408
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20678.Liking for horseradish or wasabi,18192,-0.0353831460467429,0.0242619006838241,-0.0829364713870382,0.0121701792935524,0.144752260397996
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20679.Liking for ice cream,18192,-0.00623086551822283,0.0245858910813882,-0.0544192120377438,0.0419574810012981,0.799936830588344
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20680.Liking for jam,18192,0.0412223224980436,0.0244938954601842,-0.00678571260391741,0.0892303576000046,0.0923994138902217
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20681.Liking for kiwi fruit,18192,-0.024877769775211,0.0243962516220482,-0.0726944229544254,0.0229388834040034,0.30786660514876
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20682.Liking for lager,18192,0.01327708052594,0.024611453688848,-0.0349613687042021,0.0615155297560822,0.589570895368848
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20683.Liking for lamb,18192,-0.0481817367232832,0.0246672536030969,-0.0965295537853531,0.000166080338786602,0.0508032724327927
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20684.Liking for lemons,18192,-0.0275782629191714,0.0246225512326915,-0.0758384633352468,0.0206819374969039,0.262711165050762
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20685.Liking for lentils or beans,18192,-0.030182744223583,0.0245292185955843,-0.0782600126709282,0.0178945242237622,0.218532864046816
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20686.Liking for liver,18192,0.0270815439356085,0.0245352254361344,-0.0210074979192149,0.075170585790432,0.269702267073971
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20687.Liking for mackerel,18192,-0.0229434060991885,0.0244781666920872,-0.0709206128156793,0.0250338006173024,0.348616291788494
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20688.Liking for marzipan,18192,0.00939993925097701,0.0243460101448478,-0.0383182406329246,0.0571181191348786,0.699428811811029
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20689.Liking for mayonnaise,18192,-0.0514165119237188,0.0243975694436187,-0.0992357480332114,-0.00359727581422622,0.0350927738689582
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20690.Liking for melon,18192,-0.0357596267831678,0.0251211761228984,-0.0849971319840486,0.013477878417713,0.154612670389515
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20691.Liking for milk chocolate,18192,-0.00552848696801305,0.0245316175029964,-0.053610457273886,0.0425534833378599,0.821700440651346
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20692.Liking for mushrooms,18192,-0.0385244868023533,0.0252194112532691,-0.0879545328587606,0.0109055592540541,0.126636045461716
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20694.Liking for orange juice,18192,0.047246207584478,0.0245509807311934,-0.000873714648661032,0.0953661298176171,0.054318531328144
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20695.Liking for oranges,18192,-0.0645323266443077,0.024822754414808,-0.113184925297331,-0.0158797279912839,0.00933740491578851
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20696.Liking for pasta,18192,-0.0323036276239832,0.024664703132192,-0.0806464457630796,0.0160391905151132,0.190310254767206
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20697.Liking for pears,18192,-0.0025562761573611,0.0247088965584831,-0.0509857134119879,0.0458731610972657,0.917602449913121
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20698.Liking for pizza,18192,0.0122722928798931,0.0242902018556621,-0.0353365027572046,0.0598810885169909,0.613398971928145
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20699.Liking for plain yogurt,18192,-0.0499054144366315,0.0245446200091312,-0.0980128696545287,-0.00179795921873435,0.0420415058087226
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20700.Liking for plums,18192,-0.0275598341935124,0.0250603410453797,-0.0766781026424567,0.0215584342554319,0.271460431625476
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20701.Liking for pollock,18192,-0.0180804735432682,0.0242838491225888,-0.0656768178235423,0.0295158707370059,0.456555085221932
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20702.Liking for pork chop,18192,-0.0524444972729265,0.0243204218205419,-0.100112524041189,-0.00477647050466449,0.0310657182142357
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20703.Liking for porridge,18192,-0.0276881711574517,0.0246800254937606,-0.0760610211252224,0.020684678810319,0.261925807732148
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20704.Liking for potato crisps,18192,0.0057358165753018,0.024482841125611,-0.0422505520308958,0.0537221851814994,0.814770994704004
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20705.Liking for potatoes,18192,-0.00650659976372271,0.0245926587510178,-0.0547082109157175,0.0416950113882721,0.791339973673002
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20706.Liking for prawns,18192,-0.041486585806039,0.0248085070472218,-0.0901112596185938,0.00713808800651582,0.0944878044024026
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20707.Liking for raw carrots,18192,-0.0356189074971776,0.0246187876360882,-0.0838717312639105,0.0126339162695553,0.147965128134746
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20708.Liking for red meat,18192,-0.0330484056447391,0.0245513812734058,-0.0811691129406144,0.0150723016511362,0.178289803972464
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20709.Liking for red wine,18192,-0.0742000195406109,0.0246689597104343,-0.122551180573062,-0.0258488585081597,0.00263481026488649
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,18192,0.0575104932640197,0.0250904716176413,0.0083331688934427,0.106687817634597,0.0219098195486554
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20711.Liking for roast chicken,18192,-0.0336011958498496,0.0255362726685061,-0.0836522902801215,0.0164498985804222,0.188250310155227
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20712.Liking for salad dressing,18192,-0.0320582882071314,0.0243813442925617,-0.0798457230205524,0.0157291466062896,0.188570329483216
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20713.Liking for salad leaves,18192,-0.0523333336599149,0.0249397984918648,-0.10121533870397,-0.00345132861585995,0.0358847975297137
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20714.Liking for salami,18192,-0.048276393245436,0.0245016754415712,-0.0962996771109155,-0.000253109379956519,0.0488156894631199
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20715.Liking for salmon,18192,-0.0524851212653403,0.0255750545999049,-0.102612228281154,-0.00235801424952659,0.0401645478759745
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20716.Liking for salty foods,18192,-0.00857422777985038,0.0243082572716455,-0.0562184120322756,0.0390699564725748,0.72429569236678
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20717.Liking for salty pretzels,18192,-0.073799232155372,0.0244192059922219,-0.121660875900127,-0.0259375884106171,0.00251310911870623
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20718.Liking for sardines,18192,0.00158974175457446,0.0243783444575231,-0.0461918133821708,0.0493712968913197,0.948006539738815
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20719.Liking for sausages (meat),18192,-0.0120771401828934,0.0244594358955666,-0.060017634538204,0.0358633541724173,0.621480235882962
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20720.Liking for savoury biscuits,18192,-0.0124201465941293,0.0244275385138115,-0.0602981220811998,0.0354578288929412,0.611144983795564
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),18192,-0.0389375741909515,0.0244128024047863,-0.0867866669043326,0.00891151852242969,0.110737375155757
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20722.Liking for skimmed milk,18192,-0.00619066977248388,0.0242867511683058,-0.0537927020623632,0.0414113625173954,0.798803955904511
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20723.Liking for smoked fish,18192,-0.0249942312070612,0.0245755920195341,-0.073162391565348,0.0231739291512257,0.309150438729815
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20724.Liking for soft cheese,18192,-0.00204391587405095,0.0244904926724442,-0.0500452815120416,0.0459574497639397,0.933488670067332
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20725.Liking for soy sauce,18192,-0.00441217679774863,0.0243783302193175,-0.0521937040276109,0.0433693504321137,0.856379285306898
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20726.Liking for soya milk,18192,-0.0371535431529721,0.0245402994715776,-0.0852525301172641,0.0109454438113199,0.130048094106805
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20727.Liking for spicy foods,18192,-0.00029946787510777,0.0245276945249106,-0.0483737491439325,0.047774813393717,0.990258702485107
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20728.Liking for spinach,18192,-0.089603014465074,0.0246137586211829,-0.137845981362593,-0.0413600475675554,0.000273009603080256
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20729.Liking for spirits,18192,-0.0557233010018977,0.0243388279530603,-0.103427403789896,-0.00801919821389957,0.0220627934069306
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20730.Liking for strawberries,18192,-0.0342880231931561,0.0266149517748424,-0.0864533286718473,0.017877282285535,0.197658209472201
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,18192,0.046098718908866,0.0249549759225586,-0.00281303389934881,0.0950104717170808,0.0647234494504455
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20732.Liking for sweet foods,18192,0.0288786368003856,0.0243734859171328,-0.0188933955971947,0.0766506691979658,0.236096929672236
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20733.Liking for taking the stairs,18192,-0.0534408705608034,0.0250046999024608,-0.102450082369626,-0.0044316587519803,0.0325923541365523
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20734.Liking for tea with sugar,18192,0.0993221617191047,0.029050263765852,0.0423836447380348,0.156260678700175,0.000629952082488674
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20735.Liking for tea without sugar,18192,-0.0663354622471796,0.0256040161737317,-0.116519333947694,-0.0161515905466654,0.00958233529923495
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20736.Liking for tomato ketchup,18192,0.0200699910601928,0.0243196149351916,-0.0275964542127827,0.0677364363331682,0.409235166056741
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20737.Liking for tinned tuna,18192,-0.0383670430281746,0.0244993297550891,-0.0863857293481493,0.00965164329180009,0.117355591890684
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20738.Liking for turnip (white),18192,0.0171365731282344,0.0244971341717244,-0.0308778098483454,0.0651509561048142,0.484227458807882
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20739.Liking for vegetables,18192,-0.0542703868163988,0.026889261489896,-0.106973339336595,-0.00156743429620263,0.0435755039694999
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20740.Liking for vinegar,18192,0.00065879952608744,0.0243556309263472,-0.0470782370895531,0.048395836141728,0.978420815907813
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20741.Liking for watching television,18192,-0.00759313546280781,0.0245816845215401,-0.0557732371250263,0.0405869661994107,0.757405684108944
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20742.Liking for whisky,18192,-0.0279464422479724,0.025192115817851,-0.0773229892509603,0.0214301047550155,0.267301290967649
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20743.Liking for white bread,18192,0.055020919980622,0.0241831479692912,0.00762194996081124,0.102419890000433,0.0229069641664796
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20744.Liking for white rice,18192,0.0105750920589447,0.0243400994280594,-0.0371315028200517,0.0582816869379411,0.663950871549825
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20745.Liking for white wine,18192,-0.0846064828880725,0.0243526602686932,-0.132337697014711,-0.0368752687614338,0.000513536046848072
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,18192,-0.0887120307831831,0.0245565104228751,-0.136842791212018,-0.0405812703543478,0.000303998723190013
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20747.Liking for whole milk,18192,0.0430006874639737,0.0242499803998674,-0.00452927411976642,0.0905306490477137,0.076208070860207
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20748.Liking for wholemeal bread,18192,-0.0370253538639637,0.0254655611422747,-0.0869378537028223,0.0128871459748948,0.145980694740502
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20749.Liking for working up a sweat,18192,-0.00738297209425068,0.0243440571703069,-0.0550973241480521,0.0403313799595507,0.761682887697501
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X21001.Body mass index (BMI),50058,0.0504374984113923,0.0111364941058654,0.0286099699638961,0.0722650268588884,5.93921276523744e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X21002.Weight,50098,-0.00520311884064114,0.00627867477607582,-0.0175093214017498,0.00710308372046747,0.407279842830512
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X21021.Pulse wave Arterial Stiffness index,16673,0.00497793530269167,0.00454297747528298,-0.00392630054886297,0.0138821711542463,0.273207144415866
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,17396,-0.0113349894352088,0.0264254407721689,-0.06312885334866,0.0404588744782423,0.667970530616835
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,17413,0.0652062353110614,0.0269781049785414,0.0123291495531204,0.118083321069002,0.0156589875235967
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,17415,0.0318182243325589,0.026690523346403,-0.0204952014263909,0.0841316500915088,0.233231665513458
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21040.Satisfaction with bowel habits,17341,0.0032405930172258,0.0247868526391153,-0.0453416381554402,0.0518228241898918,0.895983786764309
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,17319,0.00230675508429868,0.0264269019233917,-0.049489972685549,0.0541034828541463,0.930443492347332
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21042.Greatest number of times bowels opened per day,17329,0.0147502210656593,0.026556797958353,-0.0373011029327125,0.0668015450640311,0.578613449984959
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21043.Least number of times bowels opened per week,17209,0.00978185532395342,0.0266039152248143,-0.0423618185166825,0.0619255291645894,0.7131127992778
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21044.Average number of times bowels opened per day,17266,0.0730137482426755,0.0295534592027138,0.0150889682053564,0.130938528279995,0.0134995700048808
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,17424,-0.0204487946755649,0.0268548795370531,-0.073084358568189,0.0321867692170592,0.44639538643395
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,17414,-0.00746337066851634,0.0270178346021163,-0.0604183264886643,0.0454915851516316,0.782368039694491
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,9798,0.060615285014596,0.0425848312572127,-0.0228509842495409,0.144081554278733,0.154651875733955
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,17419,-0.027077720661414,0.0292404644407166,-0.0843890309652185,0.0302335896423904,0.354440148991229
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,17416,-0.0643896399832633,0.0397581459791919,-0.142315606102479,0.0135363261359528,0.105350696614053
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,17417,-0.0485978042645739,0.0313049603525856,-0.109955526555642,0.0127599180264939,0.120584852170345
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,17416,0.0520507032212308,0.0783051189843919,-0.101427329988177,0.205528736430639,0.506240658439537
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,17423,-0.0570958670860531,0.0305543624209632,-0.116982417431141,0.00279068325903465,0.0616862207948247
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,17420,-0.161823143241282,0.0301219972397153,-0.220862257831124,-0.10278402865144,7.87559082071995e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,17023,0.0449699613605945,0.0280396419106668,-0.00998773678431242,0.0999276595055013,0.108776842184822
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,17413,0.00184528929648374,0.027449183055373,-0.0519551094920473,0.0556456880850148,0.946402834461728
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,17420,-0.0416976208405709,0.0395502068908969,-0.119216026346729,0.0358207846655869,0.291762101797516
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,17423,-0.0615880649845983,0.026945292885561,-0.114400839040298,-0.00877529092889868,0.0222854965009974
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,17420,0.00465378113402971,0.0268068483985253,-0.0478876417270799,0.0571952039951393,0.862178559793479
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X21100.Water hardness (USGS classification),49791,-0.0501284138350631,0.0150157367123473,-0.0795592577912639,-0.0206975698788623,0.000843265860414414
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X2139.Age first had sexual intercourse,43426,-0.0110767676772785,0.00285268577752743,-0.0166680318012323,-0.00548550355332476,0.000103359722978161
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2149.Lifetime number of sexual partners,40274,0.010487484824005,0.0171724243388639,-0.0231704668801683,0.0441454365281783,0.541390653737676
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22032.IPAQ activity group,40276,-0.0216806694061614,0.0167176961101001,-0.0544473537819576,0.0110860149696348,0.19468354075156
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22033.Summed days activity,41337,-0.00618905590020867,0.00278558925311535,-0.0116488108363148,-0.000729300964102595,0.0263014019340925
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22034.Summed minutes activity,40276,-0.00686608449990883,0.00280452714043291,-0.0123629576951573,-0.00136921130466033,0.0143608456694552
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22037.MET minutes per week for walking,38556,0.000464641445645874,0.00285993384520132,-0.00514082889094872,0.00607011178224047,0.870939908268827
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22038.MET minutes per week for moderate activity,40276,-0.00406424208143986,0.00281165858827731,-0.00957509291446339,0.00144660875158368,0.148326315278259
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22039.MET minutes per week for vigorous activity,40276,-0.0610549883644481,0.0168386626303937,-0.0940587671200197,-0.0280512096088765,0.000288333009830748
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22040.Summed MET minutes per week for all activity,38556,-0.00473152797698148,0.00287309299057161,-0.0103627902385018,0.000899734284538878,0.0995988380852129
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X2217.Age started wearing glasses or contact lenses,42749,0.00083163677749852,0.00278441253182759,-0.00462581178488356,0.0062890853398806,0.765188838148467
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X22501.Year ended full time education,12221,-0.0275081586531796,0.0122673009593305,-0.0515520685334674,-0.00346424877289189,0.0249536052840656
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X22506.Tobacco smoking,12141,-0.20634080114076,0.0581298259124961,-0.320275259929252,-0.0924063423522673,0.000387197085605322
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,46990,-0.0623246892307097,0.0392977463946668,-0.139348272164257,0.0146988937028372,0.11275491050882
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23098.Weight,49249,-0.00503399870138244,0.0063287468424774,-0.0174383425126381,0.00737034510987326,0.426374269122842
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23099.Body fat percentage,49221,0.026604556251353,0.00607186590825223,0.0147036990711786,0.0385054134315274,1.18048194981849e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23100.Whole body fat mass,49172,0.0192955478237061,0.00586198298912175,0.00780606116502749,0.0307850344823847,0.000996745889101063
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23101.Whole body fat-free mass,49243,-0.0182557741528184,0.00529222400558112,-0.0286285332037574,-0.00788301510187943,0.000561998575717106
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23102.Whole body water mass,49249,-0.017747884540906,0.00529896629433167,-0.0281338584777961,-0.00736191060401594,0.00081073666491206
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23104.Body mass index (BMI),49249,0.0467307441489845,0.0111899907424098,0.0247983622938612,0.0686631260041077,2.97033198826605e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23105.Basal metabolic rate,49247,-0.017777648333825,0.00566273330978956,-0.0288766056210125,-0.00667869104663745,0.00169387724523238
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23106.Impedance of whole body,49244,0.0148747841709755,0.00433099685238943,0.00638603034029218,0.0233635380016588,0.000594149434785919
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23107.Impedance of leg (right),49246,0.0249317521836745,0.00353382681592213,0.0180054516244671,0.0318580527428819,1.74657238827676e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23108.Impedance of leg (left),49245,0.0244982698868576,0.00350987500937305,0.0176189148684864,0.0313776249052287,2.9930227221814e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23109.Impedance of arm (right),49236,-0.00092799146988045,0.00431571022737853,-0.00938678351554236,0.00753080057578146,0.829747656153831
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23110.Impedance of arm (left),49244,-0.000686538924006759,0.00432187501104973,-0.00915741394566423,0.00778433609765071,0.873786051185879
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23111.Leg fat percentage (right),49245,0.048556617935033,0.00734168098786019,0.034166923198827,0.062946312671239,3.78326762583208e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23112.Leg fat mass (right),49244,0.0351528365049775,0.00780904746499529,0.0198471034735868,0.0504585695363683,6.76133668335009e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23113.Leg fat-free mass (right),49243,-0.0288235019401331,0.00553593820318353,-0.0396739408183728,-0.0179730630618934,1.93087141403143e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23114.Leg predicted mass (right),49242,-0.0279818954468153,0.0055628812365844,-0.0388851426705207,-0.0170786482231099,4.91922947988187e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23115.Leg fat percentage (left),49239,0.0471716392433884,0.00765023397775617,0.0321771806469863,0.0621660978397905,7.05645511101989e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23116.Leg fat mass (left),49239,0.0351771597558153,0.00814396762241442,0.019214983215883,0.0511393362957476,1.56750650638121e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23117.Leg fat-free mass (left),49236,-0.0275929049473617,0.00578235402435564,-0.0389263188350988,-0.0162594910596247,1.83004745963978e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23118.Leg predicted mass (left),49235,-0.0279534750688164,0.00581170136478417,-0.0393444097437933,-0.0165625403938394,1.51481404034597e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23119.Arm fat percentage (right),49235,0.00922586979908742,0.00673653029148218,-0.00397772957221764,0.0224294691703925,0.170840400159274
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23120.Arm fat mass (right),49230,0.0113874748718947,0.0066754537187091,-0.00169641441677509,0.0244713641605646,0.0880380760831533
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23121.Arm fat-free mass (right),49231,-0.0062954622362392,0.00532826187692212,-0.0167388555150065,0.00414793104252815,0.237400859234915
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23122.Arm predicted mass (right),49230,-0.00779529109384277,0.00533569687690733,-0.0182532569725811,0.0026626747848956,0.144030159917703
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23123.Arm fat percentage (left),49225,0.00982590354543872,0.00691477748743664,-0.00372706032993709,0.0233788674208145,0.155322896631244
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23124.Arm fat mass (left),49224,0.0106905858767051,0.00666121978204177,-0.00236540489609677,0.023746576649507,0.108522420553196
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23125.Arm fat-free mass (left),49220,-0.00795648888805391,0.00543106318846594,-0.0186013727374471,0.00268839496133933,0.142928245415125
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23126.Arm predicted mass (left),49217,-0.00660486636438796,0.00544767215046159,-0.0172823037792927,0.00407257105051675,0.225357491706119
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23127.Trunk fat percentage,49213,0.0149982230708374,0.00435452781651985,0.00646334855045846,0.0235330975912163,0.000573054455203983
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23128.Trunk fat mass,49209,0.0113277738569197,0.00479182352865406,0.00193579974075772,0.0207197479730816,0.0180836627988221
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23129.Trunk fat-free mass,49202,-0.0125384820146301,0.00479992176544894,-0.0219463286749101,-0.00313063535435022,0.00899820152808128
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23130.Trunk predicted mass,49197,-0.0137193421431913,0.00480179472558621,-0.0231308598053403,-0.00430782448104234,0.0042767266734684
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23400.Total Cholesterol,28797,0.0234019633972862,0.00344244624183545,0.0166547687632887,0.0301491580312837,1.08104799066584e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,28797,0.0363455030944814,0.00333255838016768,0.0298136886693527,0.04287731751961,1.21967853891234e-27
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",28797,0.0421315848975157,0.00333649574096277,0.0355920532452287,0.0486711165498028,1.86111836929193e-36
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23403.VLDL Cholesterol,28797,0.0526954380265258,0.00334054694037541,0.04614796602339,0.0592429100296616,7.9907948225619e-56
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23404.Clinical LDL Cholesterol,28797,0.0292402057277166,0.00333928251873638,0.0226952119909932,0.0357851994644399,2.12344640255803e-18
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23405.LDL Cholesterol,28797,0.0299630849283968,0.0033294928471709,0.0234372789479419,0.0364888909088518,2.40801952124307e-19
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23406.HDL Cholesterol,28797,-0.0428133861167266,0.00387060240946394,-0.0503997668392759,-0.0352270053941772,2.20819736939196e-28
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23407.Total Triglycerides,28797,0.0457628033403363,0.00354753498487982,0.0388096347699719,0.0527159719107008,5.74435815231666e-38
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23408.Triglycerides in VLDL,28797,0.0452105065826337,0.00357393624178717,0.0382055915487308,0.0522154216165365,1.39907946676556e-36
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23409.Triglycerides in LDL,28797,0.0450586869441191,0.0034388728888637,0.0383184960819462,0.0517988778062919,4.10995574242989e-39
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23410.Triglycerides in HDL,28797,0.0313013820514944,0.00342629194167271,0.0245858498458159,0.0380169142571729,6.91654398766907e-20
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,28797,0.0177247128954521,0.0034952450503585,0.0108740325967495,0.0245753931941548,3.97989467408642e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23412.Phospholipids in VLDL,28797,0.0539356711547665,0.00342007457984864,0.0472323249782631,0.0606390173312698,8.53196181387895e-56
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23413.Phospholipids in LDL,28797,0.0317955456212988,0.00332170806336675,0.0252849978171,0.0383060934254976,1.12898435597204e-21
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23414.Phospholipids in HDL,28797,-0.0326508155374556,0.00373568927206065,-0.0399727665106944,-0.0253288645642167,2.45013989555888e-18
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23415.Total Esterified Cholesterol,28797,0.019908939323264,0.00346035001479672,0.0131266532942624,0.0266912253522655,8.83277112054031e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,28797,0.0513335499716571,0.00332147737706804,0.0448234543126037,0.0578436456307104,1.14686002488175e-53
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,28797,0.0321059565539341,0.00332205340592476,0.0255947318783216,0.0386171812295466,4.60993472964125e-22
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,28797,-0.0465098020031279,0.00385664693439743,-0.0540688299945468,-0.0389507740117089,2.07705786739773e-33
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23419.Total Free Cholesterol,28797,0.0314945465764027,0.0033997474734148,0.0248310415285097,0.0381580516242957,2.10619887686233e-20
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23420.Free Cholesterol in VLDL,28797,0.0533993015105917,0.0033865182226939,0.0467617257941117,0.0600368772270718,8.8204795518165e-56
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23421.Free Cholesterol in LDL,28797,0.0233416198920415,0.00336464377488392,0.0167469180932691,0.029936321690814,4.08048993079732e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23422.Free Cholesterol in HDL,28797,-0.0274641870712806,0.0038734400542011,-0.0350561295775147,-0.0198722445650464,1.36821122826504e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,28797,0.0310504388056958,0.0033718428472281,0.0244416268251287,0.0376592507862628,3.51700021007455e-20
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23424.Total Lipids in VLDL,28797,0.0516005077790718,0.00346628351984156,0.0448065920801824,0.0583944234779613,6.19775090014447e-50
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23425.Total Lipids in LDL,28797,0.032168013849685,0.00332417904273651,0.0256526229259215,0.0386834047734486,4.08193307005513e-22
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23426.Total Lipids in HDL,28797,-0.0343826300922813,0.00378807359362419,-0.0418072543357847,-0.0269580058487779,1.19034456138384e-19
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,28797,-0.0178425569236236,0.00355605801535681,-0.024812430633723,-0.0108726832135243,5.26569121519467e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23428.Concentration of VLDL Particles,28797,0.0538045175805438,0.00337048335724219,0.0471983702003491,0.0604106649607385,4.04205647165034e-57
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23429.Concentration of LDL Particles,28797,0.042728999180683,0.00331172137119605,0.0362380252931387,0.0492199730682273,5.5644922559328e-38
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23430.Concentration of HDL Particles,28797,-0.0271898907317777,0.00356706401572297,-0.0341813362025948,-0.0201984452609607,2.56489558411822e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,28797,0.0338458295470567,0.00371665835009777,0.0265611791808651,0.0411304799132484,9.04205037259356e-20
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23432.Average Diameter for LDL Particles,28797,-0.00186882927262071,0.00348207933155082,-0.00869370476246031,0.00495604621721889,0.591479540818041
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23433.Average Diameter for HDL Particles,28797,-0.0312158009951566,0.0039723154915616,-0.0390015393586173,-0.0234300626316959,4.02779809703095e-15
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23434.Phosphoglycerides,28774,0.00762096581588436,0.0035199880932186,0.000721789153175909,0.0145201424785928,0.0303917135861885
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,28774,0.0512937079478925,0.00376527414717511,0.0439137706194293,0.0586736452763557,3.95985453672041e-42
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23436.Total Cholines,28774,0.0076442659473336,0.00355075775414719,0.000684780749205104,0.0146037511454621,0.0313383803755163
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23437.Phosphatidylcholines,28774,0.00598933679903996,0.00356596749937365,-0.000999959499732383,0.0129786330978123,0.0930494261262034
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23438.Sphingomyelins,28773,0.0118594771398041,0.00357333134896136,0.00485574769583985,0.0188632065837684,0.000904897506853592
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23439.Apolipoprotein B,28797,0.0438390685066576,0.00331527979984608,0.0373411200989593,0.0503370169143559,8.4077675740937e-40
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23440.Apolipoprotein A1,28797,-0.0322897290364981,0.00368736024991955,-0.0395169551263404,-0.0250625029466558,2.11529368785302e-18
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,28797,0.0553127155057232,0.00337971625348851,0.0486884716488857,0.0619369593625606,6.23384560688478e-60
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23442.Total Fatty Acids,28774,0.0318104073096579,0.00338256653984347,0.0251805768915647,0.0384402377277511,5.61820973414072e-21
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23443.Degree of Unsaturation,28774,-0.0385105239131968,0.00366273637034561,-0.0456894871990741,-0.0313315606273194,8.28250845440247e-26
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23444.Omega-3 Fatty Acids,28774,-0.00109278718997617,0.0034583108953709,-0.00787107654490314,0.00568550216495081,0.752013372486644
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23445.Omega-6 Fatty Acids,28774,0.0231228022555894,0.0033851056920164,0.0164879950992372,0.0297576094119415,8.6154540634581e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,28774,0.0199455243939443,0.00340350109702139,0.0132746622437824,0.0266163865441062,4.67075383484853e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,28774,0.0400040106349722,0.00346663161440282,0.0332094126707426,0.0467986085992017,9.72215694523586e-31
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23448.Saturated Fatty Acids,28774,0.0316250224785802,0.00340012300664342,0.0249607813855591,0.0382892635716013,1.48489261631226e-20
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23449.Linoleic Acid,28774,0.0278218642127702,0.00337205949322632,0.0212126276060466,0.0344311008194938,1.64119078927748e-16
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23450.Docosahexaenoic Acid,28774,-0.0144134497974547,0.0035561582024562,-0.0213835198742689,-0.00744337972064054,5.0677133942866e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,28774,-0.0213561443052763,0.00348654566671962,-0.0281897738120467,-0.0145225147985058,9.16843797532349e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,28774,-0.0309376963923062,0.00362741216839732,-0.0380474242423649,-0.0238279685422474,1.54933894941002e-17
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,28774,-0.0401797753123134,0.00369401439590449,-0.0474200435282862,-0.0329395070963406,1.67858353099081e-27
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,28774,0.046183495775059,0.00375688550107751,0.0388200001929471,0.0535469913571709,1.20650818308158e-34
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,28774,0.0140906629413572,0.00340361940467953,0.00741956890818535,0.0207617569745291,3.48438487069178e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,28774,-0.00473383694188291,0.00362447290657076,-0.0118378038387616,0.00237012995499579,0.191537172003472
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,28774,-0.0356036210539572,0.00356822768255038,-0.0425973473117559,-0.0286098947961584,2.07790131528052e-23
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,28774,-0.0460109053510648,0.00375852509488469,-0.0533776145370388,-0.0386441961650908,2.2651951219521e-34
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,28772,0.0116037690495256,0.00345075898528912,0.00484028143835895,0.0183672566606923,0.000772927826119488
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23460.Alanine,28788,0.00412821311996527,0.00338510197073412,-0.00250658674267361,0.0107630129826041,0.222655365841047
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23461.Glutamine,28714,-0.00230080684367243,0.00336799400628366,-0.0089020750959884,0.00430046140864353,0.494524755779266
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23462.Glycine,28762,0.0116892011444277,0.00354966394788551,0.00473185980657212,0.0186465424822833,0.000992284129517769
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23463.Histidine,28760,-0.0035709306149609,0.00333918638753587,-0.0101157359345312,0.00297387470460941,0.284897813953085
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),28776,-0.00794416576100378,0.00354010916629263,-0.0148827797269373,-0.00100555179507022,0.0248370534630868
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23465.Isoleucine,28791,-0.0103434959700089,0.00345234724536493,-0.0171100965709242,-0.00357689536909365,0.00273710882553045
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23466.Leucine,28792,-0.0107983961945378,0.00352716704461085,-0.0177116436019751,-0.00388514878710054,0.00220439352599984
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23467.Valine,28776,-0.00403532644891522,0.00354854263016593,-0.0109904700040405,0.00291981710621001,0.255473139001653
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23468.Phenylalanine,28786,-0.00227491679651857,0.00337439716044516,-0.00888873523099109,0.00433890163795395,0.50020875757649
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23469.Tyrosine,28764,0.00194941506986088,0.00343490390210048,-0.00478299657825606,0.00868182671797782,0.570357779377072
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23470.Glucose,28742,-0.0115017440028912,0.00339364303704909,-0.0181532843555074,-0.00485020365027499,0.000701903722093065
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23471.Lactate,28744,0.0123005960277014,0.00336978607230643,0.00569581532598079,0.018905376729422,0.000262439121952011
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23472.Pyruvate,28713,0.00833851214876216,0.00336538943948993,0.00174234884736191,0.0149346754501624,0.0132279827707207
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23473.Citrate,28793,0.00251159552974685,0.00340547322935116,-0.00416313199978143,0.00918632305927512,0.460813820209519
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23474.3-Hydroxybutyrate,28331,-0.00539520122474374,0.00342251131291368,-0.0121033233980546,0.00131292094856707,0.114947888466625
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23475.Acetate,28772,-0.0186988602453482,0.00335830292502804,-0.0252811339784032,-0.0121165865122932,2.60054221827237e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23476.Acetoacetate,28795,-0.00971076766666532,0.00335770938163765,-0.0162918780546751,-0.00312965727865552,0.00382985815392523
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23477.Acetone,28795,-0.0232591327070421,0.00335854958816267,-0.0298418898998409,-0.0166763755142432,4.44030853232036e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23478.Creatinine,28077,0.0327933380431445,0.00399185526237118,0.024969301728897,0.040617374357392,2.21084997353804e-16
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23479.Albumin,28794,-0.0236421265228498,0.00340335335188631,-0.030312699092547,-0.0169715539531526,3.81837933393354e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23480.Glycoprotein Acetyls,28797,0.0433072562002646,0.00356578512923177,0.0363183173469703,0.0502961950535589,7.36076243972468e-34
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,28797,0.0420975991023219,0.00358659198794569,0.0350678788059483,0.0491273193986954,9.67311127390937e-32
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,28797,0.0396999367843618,0.00357905111876012,0.0326849965915919,0.0467148769771316,1.56199670462313e-28
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,28797,0.0414726966209876,0.00360094126951784,0.0344148517327326,0.0485305415092426,1.26165306080782e-30
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,28797,0.0448948114120034,0.0035662462860598,0.0379049686913262,0.0518846541326806,3.03197374036597e-36
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,28797,0.0467624278675968,0.003552065697614,0.0398003791002734,0.0537244766349203,1.81836659417503e-39
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,28797,0.041394360688751,0.00356890139404256,0.0343993139564275,0.0483894074210744,4.90913469619502e-31
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,28797,0.0357666738517347,0.00356303288607312,0.0287831293950314,0.042750218308438,1.13190571410691e-23
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,28797,0.0495514128226805,0.00360156870636842,0.0424923381581984,0.0566104874871626,6.21160704569264e-43
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,28797,0.0489420844565903,0.00359662958313073,0.0418926904736541,0.0559914784395266,4.85954600143378e-42
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,28797,0.051072650710986,0.0035735097904244,0.0440685715217542,0.0580767299002178,3.53237672942175e-46
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,28797,0.0539630881690314,0.00349487853118429,0.0471131262479102,0.0608130500901526,1.43162900338501e-53
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,28797,0.0540638295493275,0.00344598697184925,0.047309695084503,0.0608179640141521,3.05180889816417e-55
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,28797,0.052404048085844,0.00354235697395037,0.0454610284169013,0.0593470677547867,2.44791303798121e-49
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,28797,0.0440491267803471,0.00363273003170436,0.0369289759182065,0.0511692776424876,9.34045422166176e-34
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,28797,0.0501557587301765,0.00355607966999258,0.043185842576991,0.0571256748833619,5.05334400739924e-45
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23496.Total Lipids in Large VLDL,28797,0.0486333061711102,0.00354928203146367,0.0416767133894414,0.055589898952779,1.33860563751557e-42
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23497.Phospholipids in Large VLDL,28797,0.0514562656408773,0.00356849739702288,0.0444620107427124,0.0584505205390421,5.68250068275668e-47
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23498.Cholesterol in Large VLDL,28797,0.0540204757920889,0.00347827385589289,0.0472030590345389,0.060837892549639,3.56173760310178e-54
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,28797,0.0547242046457407,0.00341366607671668,0.048033419135376,0.0614149901561054,1.38082919395844e-57
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,28797,0.052261978018511,0.00354996355322689,0.0453040494541863,0.0592199065828357,7.03197916316782e-49
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23501.Triglycerides in Large VLDL,28797,0.0422118393330916,0.00356654501619458,0.0352214111013502,0.0492022675648329,3.0392060238656e-32
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,28797,0.0490659667606559,0.00333962698183733,0.0425202978762548,0.0556116356450571,1.08834114806903e-48
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,28797,0.0488639071170412,0.00336926340217814,0.042260150848772,0.0554676633853104,1.70987594731191e-47
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,28797,0.0491715114681354,0.00333147048742557,0.0426418293127813,0.0557011936234895,4.03068923219357e-49
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,28797,0.042498606060131,0.00332414551482388,0.0359832808510761,0.0490139312691858,2.5187016350733e-37
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,28797,0.0368811132461241,0.00336036779378169,0.030294792370312,0.0434674341219362,5.70724317168215e-28
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,28797,0.0477457111763083,0.00331831044621931,0.0412418227017184,0.0542495996508981,8.87505859728731e-47
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,28797,0.0448849162043914,0.00350177894089986,0.0380214294802277,0.0517484029285551,1.65220589544596e-37
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,28797,0.0536867893480665,0.0034137775023832,0.0469957854433955,0.0603777932527376,1.69569640985857e-55
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23510.Total Lipids in Small VLDL,28797,0.0531016272163178,0.00340089143411691,0.0464358800054486,0.0597673744271869,9.80340435779926e-55
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23511.Phospholipids in Small VLDL,28797,0.0510070949862899,0.00334094224574331,0.044458848184633,0.0575553417879467,2.02825539333425e-52
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23512.Cholesterol in Small VLDL,28797,0.0518569720232607,0.00333017906358277,0.0453298210586384,0.0583841229878829,1.88776337817147e-54
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,28797,0.0539258922256097,0.00334438415537623,0.0473708992810723,0.0604808851701471,3.09996870354881e-58
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,28797,0.0474719398022565,0.00331642931452378,0.0409717383457899,0.0539721412587231,2.57474517754608e-46
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23515.Triglycerides in Small VLDL,28797,0.044939010040436,0.00351514416653841,0.0380493274740207,0.0518286926068513,2.53229736604628e-37
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,28797,0.051270269715272,0.00336322187288953,0.0446783548444085,0.0578621845861355,2.87201348326355e-52
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,28797,0.0512041166298366,0.00337503346380234,0.044589051040784,0.0578191822188891,8.67397610103342e-52
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,28797,0.0537967893032584,0.00336977522029494,0.0471920298714803,0.0604015487350364,3.97448756540277e-57
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,28797,0.0442239925387075,0.00341927368174946,0.0375222161224786,0.0509257689549365,3.70957313601781e-38
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,28797,0.0406501913061975,0.00344714840432209,0.0338937804337262,0.0474066021786688,5.06196473406687e-32
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,28797,0.0509204243036921,0.00337428656451843,0.044306822637236,0.0575340259701483,2.9290539881302e-51
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,28797,0.0472268885571657,0.0034594462063099,0.0404463739927983,0.0540074031215331,2.67641941495443e-42
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23523.Concentration of IDL Particles,28797,0.0362093265078175,0.00335736353492233,0.0296288939793697,0.0427897590362653,4.56310870165346e-27
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23524.Total Lipids in IDL,28797,0.0296852814662165,0.00344452299729176,0.0229340163915247,0.0364365465409084,7.14940342446847e-18
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23525.Phospholipids in IDL,28797,0.0345158396044662,0.00344731994658925,0.0277590925091512,0.0412725866997811,1.46984207279512e-23
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23526.Cholesterol in IDL,28797,0.023889318104537,0.00346042076838287,0.0171068933985066,0.0306717428105674,5.17569261920004e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,28797,0.0228469931385646,0.0034594943689271,0.0160663841754675,0.0296276021016617,4.0678429722279e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23528.Free Cholesterol in IDL,28797,0.0262122159827654,0.00345748933009049,0.019435536895788,0.0329888950697427,3.52440661469965e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23529.Triglycerides in IDL,28797,0.0462432187332477,0.00342635478629935,0.039527563352101,0.0529588741143944,2.19680490379549e-41
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23530.Concentration of Large LDL Particles,28797,0.0414595782587479,0.00331894915084424,0.0349544379230931,0.0479647185944026,1.02477107792776e-35
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23531.Total Lipids in Large LDL,28797,0.0291305068137211,0.00334989687296098,0.0225647089427176,0.0356963046847247,3.61921512539371e-18
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23532.Phospholipids in Large LDL,28797,0.0286435634196951,0.00334521593916234,0.022086940178937,0.0352001866604533,1.15816511842793e-17
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23533.Cholesterol in Large LDL,28797,0.0267679555722827,0.00335903952979326,0.0201842380938879,0.0333516730506775,1.6593072177821e-15
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,28797,0.0282716967506289,0.00334717492947652,0.021711233888855,0.0348321596124029,3.14270362571519e-17
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,28797,0.0220880024880133,0.00339887860833112,0.0154262004156843,0.0287498045603423,8.23870528571432e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23536.Triglycerides in Large LDL,28797,0.0443008414433222,0.00342476437275043,0.0375883032727314,0.0510133796139131,3.62872723445146e-38
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,28797,0.0411441460866361,0.00331482478518375,0.034647089507676,0.0476412026655963,2.76435463642293e-35
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23538.Total Lipids in Medium LDL,28797,0.0356583716140529,0.00331556952425565,0.0291598553465118,0.042156887881594,6.32771751325635e-27
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23539.Phospholipids in Medium LDL,28797,0.0339332283081161,0.0033135966080517,0.0274385789563347,0.0404278776598974,1.43719855367783e-24
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23540.Cholesterol in Medium LDL,28797,0.0343577285525444,0.00331333914156751,0.0278635838350721,0.0408518732700168,3.77898627266884e-25
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,28797,0.0372346909455018,0.00332146172731337,0.0307246259599676,0.043744755931036,4.16911725562533e-29
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,28797,0.0249432435917832,0.00332369173184088,0.0184288077973751,0.0314576793861913,6.33580067776015e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23543.Triglycerides in Medium LDL,28797,0.0445989806340871,0.00345786247988692,0.0378215701735087,0.0513763910946654,5.89761933258327e-38
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23544.Concentration of Small LDL Particles,28797,0.0450350647014031,0.00331325178179157,0.0385410912090916,0.0515290381937145,5.98692742244868e-42
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23545.Total Lipids in Small LDL,28797,0.0388818061394327,0.0033121335598536,0.0323900243621196,0.0453735879167457,9.4805276986761e-32
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23546.Phospholipids in Small LDL,28797,0.0379929655385595,0.00331196623049526,0.0315015117267888,0.0444844193503302,2.13805029577421e-30
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23547.Cholesterol in Small LDL,28797,0.0362180389840944,0.00331060490934921,0.02972925336177,0.0427068246064189,8.41693018010384e-28
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,28797,0.0393106933887669,0.00331597012739852,0.0328113919390658,0.045809994838468,2.41229721451506e-32
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,28797,0.0254738069995317,0.00332642558644732,0.0189540128500949,0.0319936011489684,1.9474797534681e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23550.Triglycerides in Small LDL,28797,0.0461699386411352,0.00349563965702403,0.0393184849133681,0.0530213923689023,1.0314632697196e-39
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,28797,-0.00287416281769698,0.00391306526192881,-0.0105437707310774,0.00479544509568348,0.462647493069282
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,28797,-0.00970650797197236,0.00393046278410049,-0.0174102150288093,-0.00200280091513541,0.0135337456846542
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,28797,-0.0122145834103906,0.00391996557313489,-0.019897715933735,-0.0045314508870462,0.00183507162785106
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,28797,-0.0116183442516768,0.00393778485590811,-0.0193364025692567,-0.00390028593409692,0.00317539015429607
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,28797,-0.0154955009266478,0.00398034129508294,-0.0232969698650103,-0.0076940319882852,9.92320524523128e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,28797,0.00116602596209202,0.00373953027950708,-0.00616345338574186,0.0084955053099259,0.755186567335484
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,28797,0.0355973868443608,0.0033820458334876,0.0289685770107251,0.0422261966779965,7.35228262999683e-26
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23558.Concentration of Large HDL Particles,28797,-0.033460343938146,0.00403965272852914,-0.0413780632860631,-0.0255426245902288,1.25288620336222e-16
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23559.Total Lipids in Large HDL,28797,-0.0364855955810693,0.00400972605527044,-0.0443446586493994,-0.0286265325127393,9.66438565494742e-20
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23560.Phospholipids in Large HDL,28797,-0.0382771445862428,0.00396163599132467,-0.0460419511292391,-0.0305123380432465,4.7252029822058e-22
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23561.Cholesterol in Large HDL,28797,-0.0375776934012329,0.00403801323838684,-0.0454921993484711,-0.0296631874539947,1.41884216621846e-20
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,28797,-0.0397815024627379,0.00403769416417774,-0.0476953830245263,-0.0318676219009496,7.26489166292913e-23
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,28797,-0.0295354516178695,0.00401616145551512,-0.0374071280706791,-0.0216637751650598,1.9726814568251e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23564.Triglycerides in Large HDL,28797,0.0165805548052253,0.00346423773187035,0.00979064885075945,0.0233704607596912,1.70806636999643e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,28797,-0.0367475677547753,0.00365226275492865,-0.0439060027544354,-0.0295891327551151,8.94099621647402e-24
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23566.Total Lipids in Medium HDL,28797,-0.0345640888160029,0.0036072620673499,-0.0416343224680087,-0.0274938551639971,1.02752171767224e-21
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23567.Phospholipids in Medium HDL,28797,-0.0306502274740377,0.0035674463260966,-0.0376424222731871,-0.0236580326748884,8.99962503316781e-18
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23568.Cholesterol in Medium HDL,28797,-0.044598093333218,0.00367532435060636,-0.0518017290604065,-0.0373944576060296,8.38945331924662e-34
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,28797,-0.0467887033063597,0.00366231322105911,-0.0539668372196356,-0.0396105693930839,2.82935905328338e-37
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,28797,-0.0339637552053984,0.00371087043832032,-0.0412370612645062,-0.0266904491462906,5.92035556395166e-20
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23571.Triglycerides in Medium HDL,28797,0.0273140938353707,0.00342850677042869,0.0205942205653305,0.0340339671054109,1.68863376201247e-15
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23572.Concentration of Small HDL Particles,28797,-0.00797103301782465,0.00332967760425269,-0.0144972011221599,-0.00144486491348937,0.016675045951271
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23573.Total Lipids in Small HDL,28797,-0.00636529097345871,0.00335324199325395,-0.0129376452802364,0.000207063333319039,0.0576731757276736
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23574.Phospholipids in Small HDL,28797,-0.00889806811504699,0.00336862908352089,-0.0155005811187479,-0.00229555511134605,0.00825963934015708
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23575.Cholesterol in Small HDL,28797,-0.0133096029973196,0.00333012075597156,-0.0198366396790238,-0.00678256631561533,6.43826403667463e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,28797,-0.0172030697380851,0.0033209212364817,-0.0237120753615892,-0.0106940641145809,2.23128278723534e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,28797,0.000222335601654036,0.00338645779103169,-0.00641512166876807,0.00685979287207614,0.947653492956927
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23578.Triglycerides in Small HDL,28797,0.0419153203458356,0.00359021666035455,0.0348784956915407,0.0489521450001305,2.01696548254168e-31
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27562,0.00767834749940562,0.00342120238337206,0.000972790827996384,0.0143839041708149,0.0248183240145634
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27562,0.00300593322220259,0.00346712661669353,-0.00378963494651673,0.00980150139092191,0.385959920794451
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27562,0.00918550092998134,0.00343233344692563,0.00245812737400711,0.0159128744859556,0.00745133585704189
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27562,-0.00865503572929652,0.00350632516550254,-0.0155274330536815,-0.00178263840491155,0.0135776367457663
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27562,-0.00557046510511046,0.00341617054104706,-0.0122661593655627,0.00112522915534177,0.102982632079899
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,28491,0.0395720374862881,0.00333570061939141,0.033034064272281,0.0461100107002953,2.19170854923326e-32
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,28491,-0.00659629330865461,0.00364505417141061,-0.0137405994846194,0.000548012867310184,0.0703597242432159
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,28491,-0.0104882727426906,0.00363891061424419,-0.0176205375466092,-0.00335600793877195,0.00395133718477591
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,28491,0.0107629345445467,0.00354132289508911,0.00382194167017208,0.0177039274189214,0.0023738996155063
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,28491,-0.00604350876703283,0.00355292461013701,-0.0130072410029014,0.000920223468835706,0.0889547500938112
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,28792,0.0492667752014746,0.00352575033044344,0.0423563045538055,0.0561772458491438,3.16023498492529e-44
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,28792,0.0173874981070706,0.00342434485333677,0.0106757821945305,0.0240992140196107,3.8458784783834e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,28792,0.0103724599300509,0.00355165573529363,0.00341121468887534,0.0173337051712264,0.0034978900449965
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,28792,0.029872816715071,0.00335261147591123,0.0233016982222849,0.036443935207857,5.38213789000719e-19
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,28792,-0.0330875414501935,0.00331773204593905,-0.039590296260234,-0.0265847866401529,2.1851171621615e-23
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,28797,0.0178167922275636,0.00350059118201401,0.0109556335108161,0.0246779509443111,3.60976096534903e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,28797,-0.002650904,0.003658917,-0.00982238,0.004520573,0.4687616
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,28797,-0.00729559869314316,0.00368540304040959,-0.0145189886523459,-7.22087339403701e-05,0.0477587719929474
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,28797,0.0096210488653818,0.00357225371345563,0.00261943158700877,0.0166226661437548,0.00707956243857101
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,28797,-0.00211848309714724,0.00362848565753162,-0.00923031498590921,0.00499334879161472,0.559327341012247
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,28797,-0.00459079651191606,0.0035616888241833,-0.0115717066073153,0.00239011358348321,0.197429957678172
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,28797,0.00999697631464844,0.00345708389659597,0.00322109187732034,0.0167728607519765,0.00383405675879877
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,28797,0.0193801477967694,0.00337355068116917,0.0127679884616779,0.025992307131861,9.29931718337453e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,28797,-0.00483814850871552,0.00358396150954187,-0.0118627130674176,0.00218641604998655,0.177044457223556
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,28797,-0.00576020877564529,0.00349097654632904,-0.0126025228064502,0.00108210525515963,0.0989481366545749
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,28797,0.0307762950187183,0.00347930209408504,0.0239568629143116,0.037595727123125,9.6184445070787e-19
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,28797,-0.0106921229909377,0.0036422710325269,-0.0178309742146904,-0.00355327176718494,0.00333204175482499
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,28797,-0.0143580577166626,0.00367816237758595,-0.021567255976731,-0.00714885945659414,9.49900368556782e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,28797,0.0146976833894131,0.00337248017983287,0.00808762223694063,0.0213077445418855,1.31636775238989e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,28797,0.00472770708297702,0.0036189955956601,-0.00236552428451678,0.0118209384504708,0.191440976497238
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,28797,0.0217994067509649,0.00332082479774313,0.0152905901473884,0.0283082233545414,5.31109147761015e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,28797,-0.0217404478374373,0.00349654699256415,-0.0285936799428631,-0.0148872157320116,5.11450340504616e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,28797,-0.0237971192180527,0.00346861934991099,-0.0305956131438782,-0.0169986252922272,6.99157245108883e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,28797,-0.00487452975646469,0.00339886649937386,-0.0115363080952375,0.00178724858230807,0.151536517516437
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,28797,0.0180421966879408,0.00357134155085624,0.0110423672482626,0.025042026127619,4.40021264606326e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,28797,-0.00861814363035011,0.00334446987403709,-0.0151733045834628,-0.00206298267723741,0.00997591557542434
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,28797,-0.0123692137379696,0.00355428921659578,-0.0193356206024973,-0.00540280687344188,0.00050200438012654
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,28797,0.00561541166970254,0.00332456704680008,-0.000900739742025623,0.0121315630814307,0.0912176998354803
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,28797,-0.0265620302640908,0.00366833128889352,-0.0337519595903221,-0.0193721009378595,4.56876802171253e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,28797,0.0149022836600192,0.00351461634345757,0.00801363562684239,0.0217909316931961,2.24128381992595e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,28797,-0.0236349745101071,0.0033461876894912,-0.0301935023815098,-0.0170764466387043,1.66340740761109e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,28797,0.00418434196393388,0.00338132824693139,-0.00244306140005164,0.0108117453279194,0.215917286741775
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,28797,0.0318276363175966,0.00340917311674355,0.0251456570087792,0.0385096156264139,1.07132349200307e-20
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,28797,-0.0366677857876029,0.0036367067913835,-0.0437957310987146,-0.0295398404764913,7.21974562359837e-24
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,28797,0.00909688848543592,0.003443236098,0.00234814573335593,0.0158456312375159,0.00824726115720178
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,28797,-0.0164735516368003,0.00336631301640817,-0.0230715251489603,-0.00987557812464033,9.95184559951345e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,28797,0.000685052719655194,0.00335370925590433,-0.0058882174219173,0.00725832286122769,0.838146162950987
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,28797,0.0224808205497713,0.0033605409256287,0.0158941603355391,0.0290674807640036,2.2781161715047e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,28797,-0.0276158162103305,0.00351370957107586,-0.0345026869696392,-0.0207289454510218,3.99238263148478e-15
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,28797,0.0192395340859519,0.00352864062744657,0.0123233984561566,0.0261556697157472,5.01047872489846e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,28783,-0.0190265587305836,0.00376531619341306,-0.0264065784696732,-0.011646538991494,4.37331578922777e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,28783,-0.00326134695685432,0.00351655668396911,-0.0101537980574338,0.00363110414372515,0.353713050260027
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,28783,-0.0205880748626249,0.0033683121777331,-0.0271899667309817,-0.013986182994268,9.947755398387e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,28783,0.0272414275825492,0.00396123854863365,0.0194774000272272,0.0350054551378712,6.23763015302958e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,28783,0.0376991335563472,0.00370882383695878,0.0304298388359079,0.0449684282767864,3.13145852923276e-24
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,28797,-0.00560196101311913,0.00369470074354137,-0.0128435744704602,0.00163965244422195,0.129475955842254
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,28797,-0.0259441084314944,0.00378566198590884,-0.0333640059238757,-0.018524210939113,7.36424149648689e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,28797,-0.0303192034695581,0.00372391032398514,-0.037618067704569,-0.0230203392345473,4.0515031916071e-16
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,28797,0.0132222319505738,0.00365485713262826,0.00605871197062238,0.0203857519305251,0.000297723741125979
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,28797,0.0437164088361558,0.00364084338641895,0.0365803557987747,0.050852461873537,3.90769616989329e-33
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,28797,0.0408555584396195,0.00372523974485801,0.0335540885396977,0.0481570283395412,6.23924391503274e-28
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,28797,-0.0505614917990213,0.00366331777889407,-0.0577415946456537,-0.043381388952389,3.39884842821529e-43
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,28797,-0.049515477997007,0.00356266754648797,-0.0564983063881234,-0.0425326496058906,8.97013362690876e-44
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,28797,-0.0231445017714812,0.00389539022436579,-0.0307794666112382,-0.0155095369317243,2.85651588783023e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,28797,0.0520683785018048,0.00358119534711438,0.0450492356214606,0.059087521382149,1.0072367076024e-47
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,28797,-0.0173911707080454,0.00342941734790644,-0.0241128287099421,-0.0106695127061488,3.97821191431472e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,28797,-0.0210877064987746,0.00342727852547431,-0.0278051724087042,-0.0143702405888449,7.70803984834654e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,28797,-0.0255432605607337,0.00340558508113827,-0.0322182073197647,-0.0188683138017027,6.54560543459907e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,28797,0.019414668729213,0.00357378753045696,0.0124100451695174,0.0264192922889087,5.60139888607224e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,28797,0.0535361749955188,0.00364465891230312,0.0463926435274047,0.0606797064636329,1.13907368661671e-48
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,49555,0.000899006600474538,0.00290273979181804,-0.00479036339148882,0.0065883765924379,0.756783046574381
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,49555,0.00314095660859774,0.00283070007715905,-0.002407215542634,0.00868912875982947,0.267175019737555
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,46216,-0.0028061131354245,0.00270059752306781,-0.0080992842806374,0.0024870580097884,0.298777057071206
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,46216,0.00367310523488556,0.00294045686380235,-0.00209019021816704,0.00943640068793815,0.211612372773563
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,46216,-0.00332830322585778,0.00290013365134,-0.00901256518248418,0.00235595873076863,0.251124029084422
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,46216,-0.00193966367762384,0.00266106116089418,-0.00715534355297644,0.00327601619772876,0.46606280591444
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24009.Traffic intensity on the nearest road,49555,-0.0210698801139817,0.0328259145167933,-0.0854086725668966,0.0432689123389331,0.5209623374527
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24010.Inverse distance to the nearest road,49555,0.000397454851986896,0.00253460450835939,-0.00457036998439751,0.0053652796883713,0.87539413625651
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24011.Traffic intensity on the nearest major road,49555,0.00143647378617364,0.00253774531162489,-0.00353750702461115,0.00641045459695842,0.571366894933909
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24012.Inverse distance to the nearest major road,49555,0.000136162087346959,0.00257672217245627,-0.00491421337066732,0.00518653754536124,0.957857102785597
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24013.Total traffic load on major roads,49555,-0.0112128126744079,0.0227730582441411,-0.0558480068329244,0.0334223814841087,0.622458682000879
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24015.Sum of road length of major roads within 100m,49555,-0.0286435728232251,0.0221635976037964,-0.0720842241266661,0.0147970784802159,0.196235003399877
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,49555,-0.00339390049014565,0.00290062463270077,-0.00907912477023917,0.00229132378994787,0.241983058695268
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,49555,-0.00234640995483628,0.00289682208711634,-0.0080241812455843,0.00333136133591174,0.417947227997488
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,49555,-0.0038511283224577,0.00286597072394827,-0.0094684309413963,0.0017661742964809,0.179037636159171
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,49456,-0.00618053037819622,0.00281328449258359,-0.0116945679836601,-0.000666492772732377,0.0280315603316297
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24020.Average daytime sound level of noise pollution,49555,-0.00241111610504032,0.00254827931644108,-0.00740574356526484,0.00258351135518421,0.344064365574467
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24021.Average evening sound level of noise pollution,49555,-0.00239002022188285,0.00254807445531175,-0.00738424615429388,0.00260420571052818,0.348263830397418
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24022.Average night-time sound level of noise pollution,49555,-0.00240972518317094,0.00254830444840702,-0.00740440190204871,0.00258495153570682,0.344347545857889
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,49555,-0.00237497524475142,0.00254815187317369,-0.00736935291617185,0.00261940242666901,0.351321253220939
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,49555,-0.00237148006462015,0.00254817150913596,-0.00736589622252664,0.00262293609328633,0.352034252141588
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2405.Number of children fathered,22813,-0.0213609859553687,0.0245845373160013,-0.0695466790947313,0.0268247071839939,0.384922513203846
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",44217,0.00755165298158126,0.00297735147806538,0.00171604408457312,0.0133872618785894,0.0112043720124738
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",44217,-0.00504535524127518,0.00269842188136896,-0.0103342621287584,0.000243551646207984,0.0615261299532263
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24502.Water percentage, buffer 1000m",44217,0.00232631716487601,0.00268352857906776,-0.0029333988500968,0.00758603317984881,0.38600840281676
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",44217,0.00632525862352778,0.00279982244156897,0.000837606638052589,0.011812910609003,0.0238780225351541
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",44217,-0.0049729779759544,0.00271946619835853,-0.0103031317247371,0.000357175772828327,0.0674573525107871
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24505.Water percentage, buffer 300m",44217,0.00579373252799105,0.00269854980269725,0.00050457491470444,0.0110828901412777,0.0318002948154595
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",49792,0.00567144949981082,0.00285601067730103,7.36685723007977e-05,0.0112692304273208,0.0470616542508461
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",49792,0.00400852801417025,0.00268400273616038,-0.00125211734870409,0.0092691733770446,0.135315623140824
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24508.Distance (Euclidean) to coast,49792,-0.00303359994284517,0.00255500639549278,-0.00804141247801103,0.00197421259232068,0.235108669762012
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,10954,0.00842410721711695,0.0340852967589932,-0.0583830744305097,0.0752312888647436,0.804798454272039
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2704.Years since last cervical smear test,20568,-0.0223488235590391,0.0247631332910514,-0.0708845648094999,0.0261869176914217,0.366799843997323
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2714.Age when periods started (menarche),26242,0.0133228777718582,0.0209233929544214,-0.0276869724188077,0.0543327279625241,0.524296142526905
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2734.Number of live births,27063,-0.0382050419555652,0.0201112424623382,-0.077623077181748,0.00121299327061765,0.0574849919547639
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2744.Birth weight of first child,21469,-0.0290604206287815,0.0222965692715174,-0.0727616964009555,0.0146408551433926,0.19246642645398
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2754.Age at first live birth,18262,-0.0164496944763078,0.00436226261877811,-0.0249997292091129,-0.0078996597435027,0.000163167189554532
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2764.Age at last live birth,18214,-0.0187082266653732,0.00421403645887035,-0.0269677381247591,-0.0104487152059873,9.06971585515184e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2794.Age started oral contraceptive pill,20743,-0.00394118489623171,0.00471869517432845,-0.0131898274379155,0.00530745764545205,0.403599144551532
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2804.Age when last used oral contraceptive pill,18828,-0.00458466896689819,0.00408743623959951,-0.0125960439965132,0.00342670606271685,0.262026002972976
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X2867.Age started smoking in former smokers,12251,-0.0242829670323542,0.00520074196993089,-0.0344764212934188,-0.0140895127712897,3.05685498113281e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",19101,-0.0374906124415394,0.030406442292068,-0.0970872393339926,0.0221060144509139,0.217597465226798
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,19094,-0.0256449538892876,0.0334666865379549,-0.0912396595036791,0.039949751725104,0.443517395793646
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,19131,-0.0186680056918258,0.0343730279891201,-0.0860391405505012,0.0487031291668496,0.587067001099208
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",19077,-0.0537749551787058,0.0337321023911236,-0.119889875865308,0.0123399655078965,0.110912887624745
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28739.Difficulty with standing for long periods,19151,0.0559949880832214,0.0291412061260382,-0.0011217759238135,0.113111752090256,0.0546828457768151
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28740.Difficulty with taking care of household responsibilities,19195,0.0463542287073323,0.0320926728929746,-0.0165474101628979,0.109255867577563,0.148646576833017
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28741.Difficulty learning a new task,19040,-0.0124220278146127,0.0369123604480092,-0.0847702542927108,0.0599261986634853,0.736476759552513
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28742.Difficulty with joining in community activities,18348,0.0539772775248915,0.0366060962017466,-0.0177706710305319,0.125725226080315,0.140352514889138
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28743.Difficulty with being emotionally affected by health problems,19066,0.0123359375354621,0.031420002392353,-0.0492472671535498,0.0739191422244741,0.694608879833369
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,19193,0.0284792079830792,0.0443431358382752,-0.0584333382599402,0.115391754226099,0.520721054449027
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,11630,0.0599412797796452,0.0331192641349553,-0.00497247792486713,0.124855037484158,0.0703431095630247
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X2897.Age stopped smoking,12259,0.0639696135704389,0.0053892126434639,0.0534067567892496,0.0745324703516281,2.55018000463668e-32
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,17131,0.0161740697909212,0.00867203778929549,-0.00082312427609792,0.0331712638579404,0.0621868762567959
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,17131,-0.0250762233433954,0.00945050174906925,-0.0435992067715711,-0.00655323991521966,0.00797524152587704
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,17131,0.0551058217671197,0.0316637495283045,-0.00695512730835721,0.117166770842597,0.081816574028015
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,17131,0.0222757959403239,0.0323889499927111,-0.0412065460453899,0.0857581379260376,0.491613798779548
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,17131,-0.0383086450582081,0.0362130276908352,-0.109286179332245,0.032668889215829,0.290130027209311
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,17131,0.00519738202450772,0.0306036605564615,-0.0547857926661568,0.0651805567151722,0.86514680752328
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,17131,-0.0134352127016544,0.013637822329802,-0.0401653444680663,0.0132949190647575,0.324567488814667
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,17131,-0.0177846902512854,0.024769630808362,-0.0663331666356749,0.030763786133104,0.472764713005701
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29002.Recent lack of interest or pleasure in doing things,17019,0.039893270312764,0.0350649219918496,-0.0288339767912613,0.108620517416789,0.255262894001547
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29003.Recent feelings of depression,17007,-0.00343736149367785,0.0341853773515952,-0.0704407011028044,0.0635659781154487,0.91990836976474
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",17031,-0.0165195437266345,0.0277674111210421,-0.070943669523877,0.0379045820706079,0.551901115449027
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29005.Recent feelings of tiredness or low energy,17037,0.0394406999878618,0.0278126212792646,-0.0150720377194969,0.0939534376952205,0.156183848499503
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29006.Recent poor appetite or overeating,17050,0.0401826203883263,0.0382435821041856,-0.0347748005358775,0.11514004131253,0.293410236489978
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29007.Recent feelings of inadequacy,16981,0.0319275153992481,0.0371422755113937,-0.0408713446030837,0.10472637540158,0.390021493087324
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29008.Recent trouble concentrating on things,17045,0.0144812185837662,0.0366275376290244,-0.0573087551691215,0.086271192336654,0.69257904844723
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,17030,0.0543548204674451,0.0629319977117947,-0.0689918950476724,0.177701535982563,0.387760924731111
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29010.Recent thoughts of suicide or self-harm,16946,0.142063902854402,0.0684884945464086,0.00782645354344108,0.276301352165363,0.0380689483263714
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29038#0.Substances taken for depression_None of options listed,15725,-0.0216899525393252,0.0174696893532795,-0.0559305436717531,0.0125506385931027,0.214411460133678
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),15725,-0.0523654518635607,0.0336120464725423,-0.118245062949744,0.0135141592226223,0.119268318059698
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),15725,-0.00998363316932651,0.0173027610417865,-0.043897044811228,0.023929778472575,0.563950063319983
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),15725,-0.0903924888277482,0.0506256596515402,-0.189618781744767,0.00883380408927065,0.0741983387706699
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),15725,-0.0289490611007422,0.0322884315034188,-0.0922343868474431,0.0343362646459588,0.369958478272411
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),15725,-0.0282281898018259,0.0347869659005077,-0.0964106429668209,0.0399542633631692,0.41711453350278
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),15725,0.0162647637008724,0.0385446528312771,-0.0592827558484306,0.0918122832501755,0.673051239110203
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),15725,-0.0251218563774957,0.0461413416037036,-0.115558885920755,0.0653151731657634,0.586136547801416
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),15725,-0.0744416220522877,0.0340708796138754,-0.141220546095483,-0.00766269800909193,0.0289105636256076
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,15725,-0.030074809110214,0.0171444572019289,-0.0636779452259947,0.00352832700556665,0.0794157148269254
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,15725,0.0443082353969597,0.0263456440579944,-0.0073292269567094,0.0959456977506288,0.0926265364178578
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,15725,-0.0228440859238021,0.0416521376400926,-0.104482275698383,0.0587941038507794,0.583391222685388
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,15725,-0.0717261136868271,0.0535284634316243,-0.176641902012811,0.0331896746391565,0.18027703739808
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,15725,-0.0239364499316105,0.0334066493206873,-0.0894134826001577,0.0415405827369367,0.473682496206416
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,15725,-0.0490839328448625,0.0542722316404731,-0.15545750686019,0.0572896411704648,0.365795969697434
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,15725,-0.0459323108736308,0.053297608750928,-0.15039562402545,0.0585310022781881,0.38880628056335
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,15725,0.00204074225752321,0.0287896190437761,-0.0543869110682779,0.0584683955833243,0.943490457187269
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,15725,-0.0393259406491487,0.027867655264134,-0.0939465449668514,0.015294663668554,0.158214913193884
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,15725,-0.0168614018783267,0.0397617610262229,-0.0947944534897235,0.0610716497330701,0.67152732113561
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29058.Recent feelings or nervousness or anxiety,16771,-0.00579193625586627,0.0325369252176274,-0.0695643096824159,0.0579804371706834,0.858716352349228
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29059.Recent inability to stop or control worrying,16791,-0.000970148036382773,0.0336755245501234,-0.0669741761546247,0.0650338800818592,0.977017505997845
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29060.Recent worrying too much about different things,16781,-0.016678222447095,0.0310882421023958,-0.0776111769677907,0.0442547320736008,0.591633921438703
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29061.Recent trouble relaxing,16784,-0.0344530050361536,0.03303070300988,-0.0991931829355185,0.0302871728632112,0.296935543097539
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29062.Recent restlessness,16802,-0.0348517319088035,0.0467812879507296,-0.126543056292234,0.0568395924746265,0.456286383729706
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29063.Recent easy annoyance or irritability,16759,-0.0139227640579555,0.0334120012434473,-0.0794102864951122,0.0515647583792013,0.676903565403242
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29064.Recent feelings of foreboding,16747,0.030191425939376,0.0376054279599786,-0.0435152128621821,0.103898064740934,0.422074255541986
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,15725,-0.00209636128190347,0.018268711743412,-0.037903036298991,0.0337103137351841,0.908643593246593
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,15725,0.0257734652192739,0.0304469018350772,-0.0339024623774774,0.0854493928160251,0.397283785141077
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',15725,0.0237872314147919,0.0394010822086536,-0.0534388897141693,0.101013352543753,0.546038361264543
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,15725,-0.0438849113806059,0.0418668884894222,-0.125944012819873,0.0381741900586615,0.294562167366289
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#2.Symptoms of panic attack_Sweating,15725,0.00543236491100037,0.0275750453557666,-0.0486147239863022,0.059479453808303,0.843827788090874
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,15725,-0.0179492081784991,0.0297150097804936,-0.0761906273482666,0.0402922109912685,0.545822332198504
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,15725,-0.0219669819144634,0.0297153796378964,-0.0802091260047403,0.0362751621758135,0.459768546955512
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,15725,-0.0206756886538388,0.0276086480059461,-0.0747886387454931,0.0334372614378155,0.453938032602593
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,15725,-0.0292736255267261,0.0362401406486532,-0.100304301198086,0.0417570501446341,0.419236385695963
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29076.Felt loved as a child,16720,-0.0513147194366995,0.0286266409857373,-0.107422935768745,0.00479349689534565,0.0730628062225862
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29077.Physically abused by family as a child,16750,0.0693898832107076,0.0382133446415408,-0.00550827228671244,0.144288038708128,0.069410545692992
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29078.Felt hated by family member as a child,16721,0.105207748783588,0.0384929569426819,0.0297615531759313,0.180653944391244,0.00627941828578063
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29079.Sexually molested as a child,16595,0.00431915588691504,0.0519202027959808,-0.0974444415932074,0.106082753367037,0.93370278213385
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29080.Someone to take to doctor when needed as a child,16688,-0.0377522255068989,0.0410489510315904,-0.118208169528816,0.0427037185150183,0.357749159740803
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,16726,0.0522513169917946,0.0531828515081111,-0.0519870719641032,0.156489705947692,0.325875534280372
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,16621,0.0156000501333174,0.0418078368267024,-0.0663433100470193,0.0975434103136542,0.709051256825651
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,16739,-0.00700409884934075,0.0468754684593569,-0.0988800170296803,0.0848718193309988,0.881224599247365
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,16690,0.168022830818368,0.063405200707623,0.043748637431427,0.292297024205309,0.00805712988421964
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,16688,0.150452886403828,0.061171086012356,0.0305575578196104,0.270348214988046,0.0139214990899611
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29086.Experienced a violent or sexual assault,16742,-0.0140362846865191,0.0534735445104668,-0.118844431927034,0.0907718625539957,0.792946724918899
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29087.Experienced a life-threatening injury or illness,16739,0.0757195690918309,0.0333702265737064,0.0103139250073663,0.141125213176296,0.0232764066426516
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29088.Experienced a marital separation or divorce,16747,0.0180202474819633,0.0313665610119587,-0.0434582121014756,0.0794987070654023,0.565633812587942
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29089.Experienced the death of a spouse or partner,16767,0.021902100564927,0.0419059604488547,-0.0602335819148282,0.104037783044682,0.601225575540183
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,16745,-0.00913917449035146,0.0391996794338236,-0.0859705461806457,0.0676921971999428,0.815652353636708
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29091.Frequency of drinking alcohol,16748,-0.112528143936858,0.0262088049776618,-0.163897401693075,-0.0611588861806405,1.76849075398036e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,14943,-0.0678443260610105,0.0303425655062958,-0.12731575445335,-0.00837289766867076,0.0253700549705337
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,14980,-0.0843698276230433,0.0307027303017312,-0.144547179014436,-0.0241924762316503,0.00600394316575307
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29104.Ever used cannabis,16738,-0.01445702435805,0.0374804647914519,-0.0879187353492957,0.0590046866331956,0.699707780711582
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29108.Ever thought that life not worth living,16659,0.0148209758836395,0.032740033165023,-0.0493494891198056,0.0789914408870845,0.650780295406596
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29109.Ever contemplated self-harm,16698,-0.0493118084967292,0.0445098825486593,-0.136551178292101,0.037927561298643,0.267927677268487
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29111.Ever self-harmed,16724,0.018990365378257,0.0699222784209362,-0.118057300326778,0.156038031083292,0.785938733485883
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,16720,-0.0459389207768742,0.0472939451780879,-0.138635053325926,0.0467572117721781,0.331388638577642
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,16998,-0.0858431284053388,0.0390233509269639,-0.162328896222188,-0.00935736058848965,0.0278353079388323
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,16998,-0.0593273588799116,0.0301450459279181,-0.118411648898631,-0.000243068861192117,0.0490769956899995
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,16998,-0.0472026157481817,0.0323312297872885,-0.110571826131267,0.0161665946349037,0.144316898565797
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,16998,-0.0628645698918385,0.0435856103939556,-0.148292366263991,0.0225632264803144,0.14922944577776
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,16705,-0.0680185406134685,0.0295824591024775,-0.126000160454324,-0.0100369207726127,0.0215009797411641
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X29153.Pain or discomfort today,16731,-0.00358294016537713,0.027683375945333,-0.0578423570182297,0.0506764766874755,0.897022374556233
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29154.Anxiety or depression today,16731,-0.0225942473030131,0.0345952552227877,-0.090400947539677,0.0452124529336508,0.513699190944727
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29166.Frequency of confiding in someone close,16314,-0.0760333331051951,0.027198107255542,-0.129341623326057,-0.0227250428843328,0.00518740820740893
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,16678,0.0166953128641558,0.00881467462024136,-0.000581449391517313,0.0339720751198288,0.058237505444913
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,16678,-0.0244746276177405,0.00884427285421705,-0.041809402412006,-0.0071398528234751,0.00565875810123899
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,16678,-0.0235589124521848,0.0110020957637092,-0.0451230201490548,-0.00199480475531476,0.0322633993043318
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,16678,0.0128894285743014,0.011926820260047,-0.0104871391353908,0.0362659962839936,0.279841972933499
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,16678,-0.0272818760365371,0.0192442722196866,-0.065000649587123,0.0104368975140487,0.156308127639391
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,16678,-0.00500901351561835,0.00910896677602536,-0.0228625883966281,0.0128445613653914,0.582395884863367
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,16674,0.0192760166079578,0.00992696899708037,-0.000180842626319767,0.0387328758422353,0.0521802480872802
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,16674,-0.0367190412253459,0.0145134180206004,-0.0651653405457226,-0.00827274190496909,0.0114151785248546
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,16674,-0.0148847940124467,0.0223955633023942,-0.0587800980851392,0.0290105100602459,0.506295496151731
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,16674,-0.0169929267586363,0.0200888658472029,-0.0563671038191539,0.0223812503018813,0.397627481661777
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,16674,-0.0419605183187136,0.0297006211066904,-0.100173735687827,0.0162526990503995,0.157738360268952
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,16674,-0.00548382693611391,0.0142532853782857,-0.0334202662775539,0.0224526124053261,0.70043403596113
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29171.Frequency of feeling 'in tune' with people,16394,-0.0466565232112863,0.0337795722215506,-0.112864484765525,0.0195514383429529,0.167234697072362
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29172.Freuency of feeling that lacks companionship,16612,0.073579485396022,0.0303603264677353,0.0140732455192608,0.133085725272783,0.015380652555791
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29173.Frequency of feeling left out,16525,0.0285917358535152,0.0320507820169257,-0.0342277968996592,0.0914112686066897,0.37236515827613
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29174.Frequency of feeling isolated from others,16588,0.0665355230888025,0.0328410176965215,0.00216712840362035,0.130903917773985,0.0427819542128996
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29175.Tendency to bounce back quickly after hard times,16709,0.0131884615765153,0.0272789864301585,-0.0402783518265954,0.0666552749796259,0.628771259903829
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29176.Ability to make it through stressful events,16709,0.00570742436384732,0.0264566572212793,-0.0461476237898601,0.0575624725175547,0.829202922346834
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29177.Quick recovery from stressful events,16709,0.0154754399879025,0.0269541570092782,-0.0373547077502828,0.0683055877260878,0.565881298638126
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29178.Hard to snap back when something bad happens,16709,0.0116300288029619,0.0265186925975853,-0.0403466086883053,0.0636066662942292,0.660986308312101
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29179.Comes through difficult times with little trouble,16709,0.0154297343882132,0.0269091021909206,-0.0373121059059912,0.0681715746824176,0.566380226691963
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29180.Tendency to take a long time to get over setbacks,16709,-0.0190934912939991,0.0268518029375846,-0.0717230250516648,0.0335360424636667,0.47705126163736
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29181.General happiness,16615,0.0815667567496024,0.0279084982624554,0.0268661001551899,0.136267413344015,0.00347535375724229
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29182.Belief that own life is meaningful,16423,-0.0806788632500394,0.0277784385470581,-0.135124602802273,-0.0262331236978055,0.00368484045386564
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,11146,0.127707771252188,0.0313578715169235,0.0662463430790175,0.189169199425358,4.68151183798758e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2946.Father's age,10982,-0.0249224795723659,0.00782646246081461,-0.0402623459955625,-0.00958261314916923,0.00145466888231594
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2966.Age high blood pressure diagnosed,12573,0.00248082314540959,0.00632844301012872,-0.00992292515444269,0.0148845714452619,0.695056285721371
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30000.White blood cell (leukocyte) count,48656,0.021794130323053,0.00269627044908218,0.0165094402428519,0.0270788204032541,6.46015244674418e-16
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,48657,0.0195340884399751,0.00301063599635718,0.013633241887115,0.0254349349928352,8.7607150152545e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30020.Haemoglobin concentration,48657,0.0210472330453241,0.00322334281573081,0.0147294811264917,0.0273649849641565,6.65801474500614e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30030.Haematocrit percentage,48657,0.0219385372653532,0.00314818359009335,0.0157680974287703,0.0281089771019362,3.24094573559791e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30040.Mean corpuscular volume,48657,-0.00133944491014573,0.00266113639356785,-0.00655527224153872,0.00387638242124725,0.614730560327069
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,48656,-0.00261280713915043,0.00267021270561142,-0.00784642404214882,0.00262080976384796,0.32783121599361
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,48656,-0.00349156614365737,0.00260632834309957,-0.00859996969613254,0.00161683740881779,0.180365621125887
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,48657,0.0270776683855984,0.00260098435501591,0.0219797390497672,0.0321755977214296,2.3599548571282e-25
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30080.Platelet count,48657,0.000884471264688785,0.00266620017281137,-0.00434128107402151,0.00611022360339908,0.740090982861719
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30090.Platelet crit,48657,0.00136909677471349,0.00272707598424302,-0.00397597215440283,0.00671416570382982,0.615642805077923
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,48657,0.000229031568565399,0.0025580679378642,-0.00478478158964844,0.00524284472677924,0.92865867495732
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30110.Platelet distribution width,48657,0.0049755014502954,0.0025857643134636,-9.25966040932506e-05,0.0100435995046841,0.0543366178135172
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30120.Lymphocyte count,48584,0.00326885278903517,0.00265717784324724,-0.00193921578372943,0.00847692136179977,0.218629219836582
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30130.Monocyte count,48584,0.00891208621199401,0.00267396596315167,0.00367111292421675,0.0141530594997713,0.000860071107299879
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30140.Neutrophill count,48584,0.021410433521564,0.00266433194620348,0.0161883429070052,0.0266325241361228,9.49334689953842e-16
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30150.Eosinophill count,48584,0.00949735652397365,0.00259650136088475,0.00440821385663955,0.0145864991913078,0.000254706397799304
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30160.Basophill count,48584,0.0676327956715436,0.0165889313252772,0.0351184902740003,0.100147101069087,4.56963459773161e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30170.Nucleated red blood cell count,48584,-0.0353181353558563,0.0794101178094219,-0.190961966262323,0.120325695550611,0.656497994917348
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30180.Lymphocyte percentage,48585,-0.0147321426442415,0.00261162982466743,-0.0198509371005896,-0.00961334818789333,1.70026498334347e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30190.Monocyte percentage,48585,-0.00451887661844522,0.00264613109674983,-0.00970529356807489,0.000667540331184456,0.0876929021801078
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30200.Neutrophill percentage,48585,0.0116654092252678,0.00258616590478016,0.00659652405189865,0.0167342943986369,6.47662578819226e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30210.Eosinophill percentage,48585,0.00276086388473486,0.00256844330083309,-0.002273284984898,0.00779501275436773,0.282417139606895
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30220.Basophill percentage,48585,0.00686456413244452,0.00255526146064349,0.00185625166958327,0.0118728765953058,0.00722418429043502
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30230.Nucleated red blood cell percentage,48583,-0.0381921544648348,0.0795601378982205,-0.194130024745347,0.117745715815677,0.63120016639249
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30240.Reticulocyte percentage,47806,0.0114402915050351,0.00275441595284005,0.00604163623746862,0.0168389467726016,3.28087431057673e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30250.Reticulocyte count,47806,0.0148566183073093,0.00281300612534319,0.00934312630163668,0.020370110312982,1.28758168971892e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30260.Mean reticulocyte volume,47806,0.0127029205072583,0.00262267660780674,0.00756247435595706,0.0178433666585595,1.2797364251986e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30270.Mean sphered cell volume,47806,0.00665690172212199,0.0026458694463433,0.00147099760728912,0.0118428058369549,0.0118741144898066
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30280.Immature reticulocyte fraction,47806,0.0121043978121381,0.00275238785427201,0.00670971761776495,0.0174990780065112,1.09599372711339e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,47806,0.013559732019743,0.00281156571491283,0.00804906321851389,0.0190704008209722,1.41963343715818e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30300.High light scatter reticulocyte count,47806,0.0163421952073591,0.00285400613044409,0.0107483431916886,0.0219360472230295,1.03407530444941e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30500.Microalbumin in urine,15751,0.0155550743975963,0.00467584266704389,0.00639042277019023,0.0247197260250023,0.000880856423073013
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,48759,-0.0176546642359954,0.0027890692941769,-0.0231212400525821,-0.0121880884194086,2.47370577127931e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30520.Potassium in urine,48659,-0.0211943690812973,0.002596594587736,-0.0262836944732598,-0.0161050436893347,3.36312309728597e-16
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30530.Sodium in urine,48647,0.00407132744764812,0.0027152133620024,-0.00125049074187659,0.00939314563717283,0.133763348071303
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30600.Albumin,43838,-0.029126028024555,0.0028014881230313,-0.0346169447456964,-0.0236351113034137,2.74874475238699e-25
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30610.Alkaline phosphatase,47830,0.0386108422168195,0.00267430231808165,0.0333692096733795,0.0438524747602596,3.76539966128486e-47
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30620.Alanine aminotransferase,47826,0.00437896123717664,0.00283910700962422,-0.00118568850168682,0.0099436109760401,0.122989661795718
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30630.Apolipoprotein A,43569,-0.0355767530176757,0.00307031487849136,-0.0415945701795188,-0.0295589358558326,5.30581487873317e-31
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30640.Apolipoprotein B,47574,0.0379385719795892,0.00258800197249149,0.0328660881135059,0.0430110558456725,1.49748828302811e-48
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30650.Aspartate aminotransferase,47683,0.022132603370056,0.00269220183304379,0.0168558877772902,0.0274093189628218,2.0683923722559e-16
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30660.Direct bilirubin,40608,-0.020674584428783,0.00290693427940833,-0.0263721756164234,-0.0149769932411427,1.16124462475568e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30670.Urea,47810,-0.00104818674768962,0.00273871101095999,-0.00641606032917121,0.00431968683379197,0.701921702010464
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30680.Calcium,43836,-0.00651938806595144,0.00271619017439133,-0.0118431208077584,-0.00119565532414444,0.016390451876117
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30690.Cholesterol,47841,0.031071632127643,0.00263059928232114,0.0259156575342936,0.0362276067209925,3.76839511057956e-32
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30700.Creatinine,47822,0.0141746923728459,0.00317761163536041,0.00794657356753946,0.0204028111781523,8.18399023840933e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30710.C-reactive protein,47697,0.0378453637221318,0.00290298023499147,0.0321555224615485,0.0435352049827151,8.81255204227931e-39
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30720.Cystatin C,47843,0.0452932249136684,0.00303248658133149,0.0393495512142587,0.0512368986130781,2.4963359955949e-50
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30730.Gamma glutamyltransferase,47820,0.0129178414117984,0.00288942646179576,0.00725456554667872,0.0185811172769181,7.81326049554042e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30740.Glucose,43784,-0.0162877664260372,0.0027897579469459,-0.0217556920020511,-0.0108198408500232,5.30706876577387e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),47576,0.0216291357139825,0.00281786914474363,0.016106112190285,0.0271521592376801,1.67639299936639e-14
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30760.HDL cholesterol,43809,-0.0379070855721798,0.00320342856820908,-0.0441858055658696,-0.03162836557849,2.94159388454954e-32
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30770.IGF-1,47590,0.00195235016426544,0.00271822067090857,-0.00337536235071535,0.00728006267924623,0.472609364099463
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30780.LDL direct,47734,0.0379467744387842,0.00259363401461072,0.0328632517701472,0.0430302971074212,2.27709776997866e-48
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30790.Lipoprotein A,38263,0.00508299145861743,0.00289612978009745,-0.000593422910373571,0.0107594058276084,0.0792505589390902
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30810.Phosphate,43737,-0.00704198117081333,0.00281406383518085,-0.0125575462877678,-0.00152641605385887,0.0123382277714898
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30830.SHBG,43427,0.00593380212730689,0.00324354177832799,-0.000423539758215965,0.0122911440128297,0.0673434796650954
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30840.Total bilirubin,47648,-0.0159938004286634,0.0027591608011278,-0.0214017555988739,-0.0105858452584529,6.80913528211597e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30850.Testosterone,43206,0.014095639090067,0.00452927431412006,0.0052182614343917,0.0229730167457423,0.00185870957718199
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30860.Total protein,43805,-0.0116898284259002,0.00276042845438554,-0.0171002681964958,-0.00627938865530453,2.29234068439779e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30870.Triglycerides,47806,0.0389530443101339,0.00282172701534054,0.0334224593600665,0.0444836292602014,2.89217765057776e-43
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30880.Urate,47778,0.00539600751982095,0.00325187191542572,-0.000977661434413463,0.0117696764740554,0.0970509923452609
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30890.Vitamin D,45680,-0.0233623319420982,0.00292564373317135,-0.0290965936591141,-0.0176280702250824,1.43357651239727e-15
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X3137.Number of measurements made,45499,-0.0398737564836301,0.0191705562641174,-0.0774480467613001,-0.00229946620596006,0.037535905975592
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X3143.Ankle spacing width,28468,0.00764429978508777,0.00465473756814699,-0.00147898584848032,0.0167675854186559,0.100546717570749
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",28466,-0.0127468179960272,0.00359094366512966,-0.0197850675796813,-0.00570856841237307,0.000386273622955741
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X3146.Speed of sound through heel,28468,-0.0167173645507814,0.00347015504063268,-0.0235188684304215,-0.00991586067114133,1.46138523596151e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",28468,-0.0158322243108236,0.00350638780610463,-0.0227047444107887,-0.00895970421085853,6.34951417028651e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X3148.Heel bone mineral density (BMD),28447,-0.0156981505186064,0.00351021271564871,-0.0225781674412779,-0.00881813359593498,7.77415164800096e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X3526.Mother's age at death,29913,-0.002735132,0.00345632,-0.009509518,0.004039254,0.4287505
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X3581.Age at menopause (last menstrual period),15493,6.78010564793386e-05,0.00460221203006868,-0.00895253452245528,0.00908813663541395,0.988245959715925
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",9883,0.0098805193306754,0.00570412851341986,-0.00129957255562753,0.0210606112169783,0.0832745729252811
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4100.Ankle spacing width (left),16122,0.00425509035230676,0.00611414501655379,-0.00772863388013868,0.0162388145847522,0.486475189743918
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),16118,-0.00915002359773975,0.00470870039283746,-0.0183790763677012,7.90291722216636e-05,0.0520074245433015
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4103.Speed of sound through heel (left),16122,-0.0128321776681478,0.00454955857543546,-0.0217493124760013,-0.00391504286029425,0.00480026206558568
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",16122,-0.011846445884813,0.00459736330588654,-0.0208572779643507,-0.00283561380527543,0.00998102894721216
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4105.Heel bone mineral density (BMD) (left),16112,-0.0121782553210139,0.00459795351398544,-0.0211902442084254,-0.00316626643360247,0.00808987686889211
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",16122,-0.0118537245231982,0.00459736859948082,-0.0208645669781806,-0.00284288206821576,0.00993551364640694
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4119.Ankle spacing width (right),16116,0.00691190628661658,0.00601722417722146,-0.00488185310073749,0.0187056656739706,0.250702193402808
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),16115,-0.00463596006014004,0.00472738241018225,-0.0139016295840973,0.00462970946381716,0.326774624892778
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4122.Speed of sound through heel (right),16116,-0.00841954016787713,0.00455890100353105,-0.017354986134798,0.000515905799043717,0.0647893225651495
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",16116,-0.0074637727922176,0.00461126765688378,-0.0165018573997098,0.00157431181527461,0.105554109515777
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4124.Heel bone mineral density (BMD) (right),16102,-0.00732493870566674,0.00461867888175637,-0.0163775493139092,0.00172767190257575,0.112773010656929
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",16116,-0.00746550514240352,0.00461126921280025,-0.016503592799492,0.00157258251468496,0.105473366870231
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4194.Pulse rate,16758,0.0040786729437251,0.00438757619274248,-0.00452097639405016,0.0126783222815004,0.352593739930442
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4195.Pulse wave reflection index,16758,0.00318364620125105,0.00450091213583615,-0.00563814158498781,0.0120054339874899,0.479369059324013
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4196.Pulse wave peak to peak time,16747,-0.00574529931260162,0.00448049190899911,-0.0145270634542399,0.00303646482903663,0.199757967502014
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4198.Position of the pulse wave peak,16758,0.0150068001625023,0.00451449460273775,0.00615839074113636,0.0238552095838683,0.000888828316276572
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4199.Position of pulse wave notch,16758,0.0119042929590302,0.00437832999582708,0.0033227661672091,0.0204858197508512,0.00655645525211084
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4200.Position of the shoulder on the pulse waveform,16758,0.011331045630611,0.00454107646032666,0.00243053576837073,0.0202315554928512,0.0125969828132231
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4269.Number of triplets attempted (left),16441,-0.0133432636334252,0.0791705503677591,-0.168517542354233,0.141831015087383,0.866161955238997
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4270.Volume level set by participant (left),16266,-0.0129347028769861,0.0256959290222583,-0.0632987237606123,0.0374293180066402,0.61470706890508
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4276.Number of triplets attempted (right),16449,0.0371580052941429,0.0784582417373828,-0.116620148511127,0.190936159099413,0.635789816628854
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4277.Volume level set by participant (right),16256,0.0380971414862176,0.0256512820910345,-0.01217937141221,0.0883736543846453,0.137511736153223
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X4288.Time to answer,16795,-0.00117204187379699,0.00505784384399055,-0.0110854158080185,0.00874133206042449,0.816752440276221
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X4290.Duration screen displayed,16795,0.00590448340238186,0.00462371164727865,-0.0031579914262843,0.014966958231048,0.201619639273674
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X46.Hand grip strength (left),50032,-0.00586434684925997,0.00365821213563781,-0.0130344426351101,0.00130574893659013,0.108926919484332
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X47.Hand grip strength (right),50038,-0.0089474870783962,0.00362851975593884,-0.0160593858000363,-0.00183558835675607,0.013671116897561
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X48.Waist circumference,50176,0.02415292,0.005654019,0.01307104,0.0352348,1.942453e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X4803.Tinnitus,16497,0.0541937229557464,0.0301318062966567,-0.00486461738570065,0.113252063297193,0.0721073293054652
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X4825.Noisy workplace,16700,0.0678733294068846,0.0333761091482092,0.00245615547639447,0.133290503337375,0.0420087196615588
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X4836.Loud music exposure frequency,16602,0.112789782904738,0.0425005818806115,0.0294886424187393,0.196090923390736,0.00796572253534064
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X49.Hip circumference,50167,-0.00876808376490663,0.00453025504549452,-0.0176473836540759,0.000111216124262636,0.0529406683105254
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X50.Standing height,50124,-0.00797192905614542,0.00359591280355202,-0.0150199181511074,-0.000923939961183471,0.0266315466318174
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X5057.Number of older siblings,14725,0.0323369981541887,0.0276967498647554,-0.0219486315807319,0.0866226278891093,0.24301223852894
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X51.Seated height,49898,-0.00171639779906769,0.00334285613863424,-0.00826839583079079,0.00483560023265542,0.607637112261145
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5181.Ever had eye surgery,11336,0.0478797214108824,0.0617143934715669,-0.0730804897933888,0.168839932615154,0.437867073211181
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5186.Duration visual-acuity screen displayed (right),11307,-0.00451201999069818,0.00532083996358856,-0.0149408663193317,0.00591682633793539,0.39646141693749
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5188.Duration visual-acuity screen displayed (left),11305,-0.0121379202708275,0.00536753060845748,-0.0226582802634042,-0.00161756027825082,0.0237559016675624
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5190.Duration at which refractometer first shown (right),11178,-0.00805271623596401,0.00539285291598247,-0.0186227079512896,0.00251727547936162,0.135407848374885
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5193.Duration at which refractometer first shown (left),11175,-0.00627199998739127,0.00542434621990254,-0.0169037185784002,0.00435971860361771,0.247596149002943
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5199.logMAR, initial (right)",11267,-0.0368664514844168,0.0327193004548952,-0.100996280376011,0.0272633774071779,0.259872486873024
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5200.Final number of letters displayed (right),11267,-0.266338031801759,0.202861921512581,-0.663947397966418,0.1312713343629,0.189242402836065
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5201.logMAR, final (right)",11158,0.0006190387491546,0.0054181184850437,-0.010000473481531,0.0112385509798402,0.909038937676292
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5202.Number of rounds to result (right),11267,-0.0639092966251489,0.0306777883584541,-0.124037761807719,-0.00378083144257874,0.0372515925865999
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5206.logMAR, initial (left)",11260,0.00898766638497065,0.0326365611485462,-0.0549799934661798,0.0729553262361211,0.783024420729648
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5207.Final number of letters displayed (left),11260,0.240042683082836,0.202005662129287,-0.155888414690567,0.635973780856239,0.234741593580672
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5208.logMAR, final (left)",11149,-0.000240353914123774,0.00541169650412828,-0.0108472790622152,0.0103665712339677,0.964575371654003
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5209.Number of rounds to result (left),11254,0.0129650980619606,0.0308238055271429,-0.0474495607712394,0.0733797568951606,0.674040897249567
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",10773,0.013134961958571,0.00535980553259305,0.0026297431146886,0.0236401808024534,0.0142759952090577
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",10773,0.0107829389896534,0.00534044916897661,0.000315658618459285,0.0212502193608476,0.0435008382385833
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5256.Corneal hysteresis (right),10773,-0.00643649130249357,0.00540877896751654,-0.017037698078826,0.00416471547383884,0.23406942849374
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5257.Corneal resistance factor (right),10773,0.00211227204178981,0.00538449079608758,-0.00844132991854186,0.0126658740021215,0.694853074021955
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",10749,0.0115045995686366,0.0053836844091388,0.000952578126724541,0.0220566210105487,0.0326255744737726
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",10749,0.00799445298822899,0.00533879588825582,-0.00246958695275242,0.0184584929292104,0.134311788855966
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5264.Corneal hysteresis (left),10749,-0.00818692032141118,0.00544060394628761,-0.0188505040561349,0.00247666341331253,0.132409674181746
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5265.Corneal resistance factor (left),10749,-0.000564057972818821,0.00539101548605829,-0.0111304483254931,0.0100023323798554,0.916671948949627
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,11232,-0.0918094986973232,0.149706383497757,-0.385234010352927,0.201615012958281,0.539714390230066
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",50016,0.00692773328625153,0.0145732624080987,-0.021635861033622,0.035491327606125,0.634523318937591
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",50016,0.000813496371285716,0.0159275594391949,-0.0304045201295362,0.0320315128721076,0.959266147573262
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",50016,0.0299889173593895,0.0151882740614028,0.000219900199039946,0.059757934519739,0.0483328774928847
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",50016,-0.0288719655695476,0.00649201314993565,-0.0415963113434214,-0.0161476197956737,8.71412587896922e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",50016,0.0172463477323916,0.0059753016404178,0.00553475651717271,0.0289579389476105,0.00390001501189871
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",22588,0.00451798287163539,0.00766972559760371,-0.0105146792996679,0.0195506450429387,0.55582216949794
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",22588,-0.000690401805732947,0.0208692334595291,-0.04159409938641,0.0402132957749441,0.973609266735109
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",22588,-0.0251183308728483,0.0148945171553045,-0.0543115844972451,0.00407492275154848,0.0917297936063085
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",22588,0.013390847924895,0.00907572891889489,-0.00439758075613901,0.031179276605929,0.140103662964701
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,50167,-0.0113148280344522,0.00998740360017111,-0.0308901390907876,0.00826048302188315,0.257257523965062
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,50167,0.0218734448078309,0.0129043927145772,-0.00341916491274034,0.0471660545284022,0.0900742908370946
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),50167,-0.0235856521028525,0.00990698164290908,-0.0430033361229543,-0.00416796808275073,0.0172830117819223
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',50167,-0.0102294301082833,0.0162580893442594,-0.0420952852230317,0.0216364250064651,0.529227424940903
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),50167,0.0757570041801302,0.039287746459124,-0.00124697887975279,0.152760987240013,0.053828387678302
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),50167,0.0301438197831897,0.0273679455621827,-0.0234973535186884,0.0837849930850678,0.270715738555752
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,50167,0.0331257995952848,0.0427276044155814,-0.0506203050592548,0.116871904249824,0.43817867591701
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,50015,-0.00563133052672347,0.00831869688721254,-0.0219359764256601,0.0106733153722131,0.498441674667911
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,50015,0.0158677869839006,0.0142234634594905,-0.0120102013967008,0.043745775364502,0.264596009361762
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,50015,-0.0137853130935465,0.00745951752861409,-0.0284059674496301,0.000835341262537155,0.0646058260230946
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,50015,0.0233855457536889,0.0124628824465804,-0.00104170384160866,0.0478127953489865,0.0606040680011466
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,50015,0.01251997647099,0.0123977216111506,-0.0117795578868651,0.0368195108288451,0.312566740868343
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,50015,0.045121288285975,0.00695790484685131,0.0314837947861464,0.0587587817858036,8.96185741748637e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,15611,0.147926788499831,0.0168736916756286,0.114854352815599,0.180999224184063,2.0266008463815e-18
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,15611,0.0689253949469026,0.0145277098965181,0.0404510835497272,0.0973997063440781,2.10969306609282e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,15611,0.0127859416756517,0.0201308561201988,-0.0266705363199379,0.0522424196712413,0.525345465558216
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,15611,-0.0702020746616381,0.016046724683841,-0.101653655041967,-0.0387504942813097,1.22302471414297e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,49957,0.00827634469265069,0.0211032476676277,-0.0330860207358995,0.0496387101212009,0.694924337569843
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,49957,0.0566893394136003,0.0313268431924484,-0.00471127324359848,0.118089952070799,0.070362442256741
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,49957,0.0985693441742688,0.0562817059775792,-0.0117427995417865,0.208881487890324,0.079890620696813
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,49957,0.118769155166179,0.0536437825315378,0.0136273414043652,0.223910968927993,0.0268309436662315
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,49957,0.0287253044563635,0.0182946710291091,-0.00713225076069025,0.0645828596734173,0.116387485023742
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,49957,0.0271185631132828,0.0243713596284867,-0.0206493017585511,0.0748864279851168,0.265832933722698
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,49957,0.00166025954615886,0.0112902036937832,-0.0204685396936563,0.023789058785974,0.883090695157733
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",16168,0.011758517015015,0.0178839487279596,-0.0232940224917858,0.0468110565218157,0.510875282415013
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",16168,0.171507254533737,0.0192511626466155,0.13377497574637,0.209239533321103,5.69245054715494e-19
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",16168,0.0610959662528012,0.0261401093484076,0.00986135192992235,0.11233058057568,0.0194383464775021
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",16168,-0.00208623565393183,0.00918655855966213,-0.0200918904308696,0.015919419123006,0.820351548992058
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",22744,-0.0025454783702942,0.00880933520533656,-0.0198117753727539,0.0147208186321654,0.772620454466511
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",22744,-0.0091623378588437,0.00860532921408017,-0.0260287831184408,0.00770410740075343,0.287010193273267
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",22744,0.0166535642690206,0.00786249982179331,0.0012430646183057,0.0320640639197355,0.0341773854628044
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",22745,-0.00381306796744996,0.0186186044841244,-0.0403055327563337,0.0326793968214338,0.837731153603903
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",22745,0.0476031899454995,0.0111499875850686,0.0257492142787652,0.0694571656122339,1.96838842209179e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",22745,-0.00297356670797224,0.0150274846141123,-0.0324274365516324,0.0264803031356879,0.843144467852696
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,50015,0.0413114947896737,0.0173830001100679,0.00724081457394062,0.0753821750054068,0.0174793368511017
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,50015,-0.004230349581468,0.0121994485180464,-0.028141268676839,0.019680569513903,0.728768851324874
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,50015,-0.0163274730464409,0.0335824781412871,-0.0821491302033637,0.0494941841104819,0.626834422633414
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,50015,0.00750989301542519,0.0125324263454349,-0.0170536626216272,0.0320734486524776,0.549017596904025
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,50015,0.0158933923250609,0.0143388684334821,-0.012210789804564,0.0439975744546859,0.267688699676546
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),50015,0.0429540740560708,0.0164460217594761,0.0107198714074977,0.075188276704644,0.00900881575181613
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,50015,0.00317178740443863,0.00540943823803422,-0.00743071154210844,0.0137742863509857,0.557647543091736
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,9731,0.0587660362984648,0.0158964864462872,0.0276089228637418,0.0899231497331878,0.00021954075761839
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,9731,0.0955645848760084,0.0197788877549732,0.056797964876261,0.134331204875756,1.37479963575808e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,9731,-0.0356992373176801,0.0140681380960827,-0.0632727879860022,-0.00812568664935805,0.0111771988386394
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,9731,-0.011522312523929,0.0125533513591988,-0.0361268811879587,0.0130822561401007,0.358711048994855
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,50244,0.0211484792696377,0.00632984435023896,0.00874198434316937,0.0335549741961061,0.000835157432220318
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,50244,0.0164138057939875,0.0182113438495296,-0.0192804281510905,0.0521080397390654,0.36743544403097
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,50244,0.0190332346897822,0.00592066131404516,0.00742873851425367,0.0306377308653107,0.00130656901961265
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,50244,0.0127804808157971,0.00572766399776787,0.00155425938017209,0.0240067022514221,0.0256616816426553
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,50244,0.0084765120438008,0.00886346659240419,-0.00889588247731142,0.025848906564913,0.338903699356821
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,50244,0.0251093091494226,0.00790759846625883,0.00961041615555529,0.0406082021432899,0.00149751689666773
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,50244,-0.00503103197767638,0.00615722134427254,-0.0170991858124506,0.0070371218570978,0.413878275018548
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,50244,0.0701492061863268,0.0182838221382435,0.0343129147953696,0.105985497577284,0.000124860358000087
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,34767,-0.0158667252425192,0.00613352936947977,-0.0278884428066996,-0.00384500767833884,0.00968885961941282
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,34767,0.00113938488901073,0.00640266159083982,-0.0114098318290353,0.0136886016070568,0.858759446090585
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,34767,-0.00630565269086155,0.0072157430434408,-0.0204485090560055,0.00783720367428241,0.382192728481015
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,34768,-0.000544920235101981,0.00990449834345014,-0.0199577369882643,0.0188678965180603,0.956124878593292
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,34768,-0.00728808345274062,0.00647285491307083,-0.0199748790823594,0.00539871217687821,0.26019625947101
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,49781,0.00657884323644701,0.00638490955237768,-0.00593557948621324,0.0190932659591073,0.302839595440856
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,49781,-0.0126548818317649,0.00507939644196348,-0.0226104988580133,-0.00269926480551646,0.0127267902058262
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,49781,-0.0129487283934034,0.00563386477855053,-0.0239911033593625,-0.0019063534274444,0.0215446362925455
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,49781,-0.0268804248567108,0.0101931478947322,-0.046858994730386,-0.00690185498303563,0.00836423513876657
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),49816,-0.0296794063815351,0.00561110527344224,-0.0406771727174818,-0.0186816400455883,1.23232205149e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,49816,-0.0116772370813253,0.00875261932036288,-0.0288323709492365,0.00547789678658595,0.182163422544689
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),50015,-0.0147352925920097,0.00552472331094257,-0.0255637502814572,-0.0039068349025623,0.0076521047066833
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,50015,-0.0209815734454256,0.00654574266247292,-0.0338112290638725,-0.00815191782697864,0.00134970350060277
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,50015,0.00480637065019816,0.0098638004850646,-0.0145266783005284,0.0241394196009248,0.626066512526398
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,50015,-0.0136780450292106,0.0125401376556877,-0.0382567148343586,0.0109006247759374,0.275392024100205
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,50015,0.0226256337663561,0.0136483671548819,-0.00412516585721254,0.0493764333899247,0.0973734244714743
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,50015,-0.0150225647987286,0.016225531224278,-0.0468246059983135,0.0167794764008564,0.354523387102421
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",28468,-0.0158328191032262,0.00350639384937,-0.0227053510479914,-0.00896028715846096,6.34466991035787e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X864.Number of days or week walked 10+ minutes,49154,-0.0175817461369241,0.0149227971174068,-0.0468304284870414,0.0116669362131933,0.238730425853089
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X874.Duration of walks,42580,0.00351314268614689,0.00270169343564526,-0.00178217644771782,0.0088084618200116,0.193488633338013
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,47518,-0.0185647325162971,0.0145084766619823,-0.0470013467737825,0.00987188174118827,0.200699720959346
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X894.Duration of moderate activity,36779,0.0214239386777584,0.0175575380937807,-0.0129888359860517,0.0558367133415686,0.222391913995741
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X90087.No-wear time bias adjusted average acceleration,10475,0.000928586263762328,0.00570805587691371,-0.0102592032549885,0.0121163757825132,0.870773573815289
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,47438,-0.0562852428110851,0.015042195052691,-0.0857679451143595,-0.0268025405078107,0.000182904895751268
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X914.Duration of vigorous activity,26558,0.00223702459404928,0.00333953491741769,-0.0043084638440894,0.00878251303218795,0.502952154832161
